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ABSTRACT
Shakya, Sapana. Screening for Melanoma for At-Risk Population: A Practice Guide.
Unpublished Doctor of Nursing Practice scholarly project, University of
Northern Colorado, 2019.

Melanoma is a lethal skin cancer that kills one American every hour
(American Academy of Dermatology, 2018b). The incidence and prevalence rate of
melanoma is on the rise and continues to affect people, increasing the mortality and
morbidity rate and financial burden of the disease.
In 2016, the U.S. Preventive Services Task Force concluded that there was
insufficient evidence to assess the balance of benefits and harms of visual skin
examination by a clinician to screen for skin cancer in adults. However, this
recommendation was only applicable to the patients who were asymptomatic. The
routine skin cancer screening has shown promising results in patients who are at high
risk for melanoma (American Cancer Society, 2018b). Primary care providers do not
perform routine skin cancer screenings for melanoma or do not even perform
screening to identify if the patients are at high risk for melanoma or not. Thus there is
a lack of a standardized screening tools/models and workflow processes to include
melanoma screening in the clinic settings.
To address this need, an evidence-based melanoma screening workflow
algorithm was developed specifically to a federally qualified health center in a rural
and small mountain community in Northern Colorado. The workflow algorithm
included the self-assessment of melanoma risk score (SAMScore) as the risk
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prediction model to screen patients at high risk for melanoma. The Doctor of Nursing
Practice (DNP) scholarly project was implemented to screen patients for melanoma
between ages 35 to 75 years old for annual exams, excluding well women visits, who
were able to speak, read, and write in English. Depending on the screening result, an
appropriate intervention was done by the providers of the clinic by performing a fullbody skin exam or biopsy or referral or educating patients on primary prevention of
melanoma. The project was evaluated by utilizing the Donabedian framework.
After implementation, there was a 300% increase in the number of melanoma
screenings completed, increased awareness on melanoma, and melanoma screening
protocols among the providers and patients. The clinic has continued to utilize the
melanoma screening algorithm and SAMScore to screen patients for melanoma and
continues to distribute the handout on primary prevention of melanoma by the
American Association of Dermatology. Further studies are needed to assess the
validity of the SAMScore in languages other than English and French and evaluate the
effectiveness of the SAMScore and the melanoma screening algorithm in a larger
clinic with a greater number of staff.
Keywords: melanoma screening, melanoma guideline, melanoma algorithm,
skin cancer
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CHAPTER I
INTRODUCTION
Background
Melanoma is defined as “the cancerous growth of the skin cells due to
unrepaired deoxyribonucleic acid damage that causes cells to multiply rapidly and
form malignant tumors” (Skin Cancer Foundation, 2019, p. 1). It is highly aggressive
and metastatic. Metastatic melanoma is a fatal disease with rapid systemic
dissemination (Tas, 2012).
Skin is the largest organ of the body and consists of two main layers, the
epidermis and the dermis (National Cancer Institute, 2019). The outer layer of the
skin, the epidermis, consists of three cell types: squamous, basal, and melanocytes
(National Cancer Institute, 2019). Squamous cells are the thin flat cells forming the
top of the epidermis (National Cancer Institute, 2019). Basal cells are round cells
located underneath the squamous cells (National Cancer Institute, 2019). Melanocytes
are located under basal cells and produce a pigment called melanin that gives skin its
color (National Cancer Institute, 2019). The uncontrolled proliferation of melanocytes
is called melanoma. It is one of the most aggressive forms of skin cancer and can
metastasize to other parts of the body via the lymphatic system and bloodstream
(Dinnes et al., 2018). The most common target sites for metastasis for melanoma
include the liver, bone, and brain (Tas, 2012). Approximately 4% of newly diagnosed
melanoma patients will have the disease metastasized to other parts of the body at the
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time of diagnosis (Tas, 2012). With any metastatic disease, including metastatic
melanoma, the median survival time is about 12 months (Tas, 2012). Basal and
squamous cells can proliferate in an uncontrolled manner and become basal cell
carcinoma and squamous cell carcinoma. However, these malignancies are not as
aggressive as melanoma and rarely metastasize to other organs or parts of the body
(National Cancer Institute, 2019).
Risk Factors of Melanoma
Early diagnosis is the principal factor that can improve the prognosis of
melanoma. Early diagnosis refers to catching the localized melanoma before it
metastasizes to other organs or parts of the human body. The five-year survival rate
for the localized melanoma is about 98% compared to regional melanoma of 64% and
distant melanoma metastasis of 23% (American Cancer Society, 2019b). The etiology
of melanoma is complex and heterogeneous. The risk of developing melanoma
depends on both environmental and genetic factors (Craythome & Al-Niami, 2017).
Prolonged exposure to ultraviolet radiation is the greatest risk factor for melanoma
(Watson, Holman, & Maguire-Eisen, 2016). The ultraviolet radiation causes
deoxyribonucleic acid damage through the formation of pyrimidine dimers,
photoproducts, gene mutations, oxidative stress, inflammation, and
immunosuppression (Potrony et al., 2015). A study was conducted on the joint effects
of sun exposure during childhood and adulthood on melanoma risk (Oliveria, Geller,
Heneghan, & Jorgensen, 2006). The odds ratio of having melanoma in adults with
intense childhood and adulthood sun exposure was 4.5% compared to 2% of
low/moderate childhood and adulthood sun exposure (Oliveria et al., 2006).
Occupational exposure and intense exposure to ultraviolet radiation such as indoor
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tanning are also highly associated with melanoma (Watson et al., 2016). Indoor
tanning before the age of 35 years increases the risk of melanoma by 59% and the risk
increases with each use (American Academy of Dermatology, 2018a). Only one
indoor tanning session can increase the risk of melanoma by 20% (American
Academy of Dermatology, 2018a).
Furthermore, genetic factors also strongly influence the risk of melanoma.
Melanocyte produces a pigment called melanin that gives color to skin and eyes. The
melanin absorbs and scatters the energy from ultraviolet light protecting the epidermal
cells from damage (Watson et al., 2016). Thus the amount of melanin or the degree of
pigmentation is inversely related to sun sensitivity and skin cancer risk (Watson et al.,
2016). Some of the characteristics that increase the risk of melanoma include
naturally fair skin tone or skin type of Fitzpatrick I; light color eyes; blonde or red
hair; dysplastic nevi or common moles (more than 50 moles); and sensitive skin that
burns, freckles, reddens, or becomes painful after sun exposure (Watson et al., 2016).
In addition, the personal and family history of melanoma increases the risk of
melanoma (Watson et al., 2016).
According to the Aim at Melanoma Foundation (2014a), at least 5% of people
with a past history of melanoma will develop a new melanoma, putting them at
increased risk for melanoma. The risk of melanoma multiplies by 30 to 70 times with
multiple first-degree family members (Aim at Melanoma Foundation, 2014a). The
Skin Cancer Foundation (2019) stated that a person with a first-degree relative
diagnosed with melanoma is 50 times more likely to develop the disease compared to
a person without a family history of melanoma. Immunosuppressed individuals who
do not have the ability to right infections or at risk for infection are also at an
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increased risk for melanoma. Melanoma high-risk genes are genes that put an
individual at high risk for developing melanoma. The two genes that are associated
with melanoma susceptibility are cyclin-dependent kinase inhibitor 2A and cyclindependent kinase 4 (Potrony et al., 2015). Also, genetic syndromes are responsible for
the development of melanomas such as familial atypical mole melanoma syndrome
and xeroderma pigmentosum (Watson et al., 2016).
Statistical Significance
of Melanoma in the
United States
Melanoma is the deadliest type of skin cancer, ranking it as the fifth and the
seventh most common cancer among males and females in the United States,
respectively (Jiang et al., 2017). The incidence of melanoma is rising rapidly and is
expected to double by 2030 (Robinson et al., 2018). The Centers for Disease Control
and Prevention (2015) stated that the incidence rate of melanoma has increased from
11.2 per 100,000 in 1982 to 22.7 per 100,000 in 2011. The incidence rate of
melanoma is higher in women compared to men before the age of 50 (American
Academy of Dermatology, 2018b). It is the second most common cancer in females
between ages 15 to 29 years, and the incidence rate of melanoma increased up by
800% in women ages 18 to 39 years from 1970 to 2009 (American Academy of
Dermatology, 2018b). The risk of melanoma increases with age among men. The rate
is twice as high in men by age 65 years and three times as high in men by age 80 years
(American Academy of Dermatology, 2018b). The annual incidence rate of
melanoma in non-Hispanic Caucasians is 26 per 100,000 compared to 4 per 100,000 in
Hispanics and 1 per 100,000 in African Americans (American Academy of
Dermatology, 2018b). It has been estimated that melanoma will affect one in 27 men
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and one in 40 women in their lifetime (American Academy of Dermatology, 2018b).
According to the American Cancer Society (2019a), the lifetime risk of getting
melanoma is 2.6% (one in 38) for Whites, 0.1% (one in 1,000) for Blacks, and 0.58%
(one in 172) for Hispanics. The median age of diagnosis of melanoma is 63 years, and
the median age of death related to melanoma is 69 years (U.S. Preventive Services
Task Force, 2016). Johnson et al. (2017) recommended the screening age of
melanoma as 35 to 75 years compared with the U.S. Preventive Services Task Force
cancer recommendations for colorectal, cervical, breast, and lung cancer.
The mortality rate of melanoma is on the rise. According to the American
Academy of Dermatology (2018b), melanoma kills one American every hour. In
2012, 55,488 deaths were attributed to malignant melanoma globally (Johansson,
Brodersen, Gotzsche, & Jorgensen, 2016). Even though melanoma accounts for 1% of
skin cancers, it is responsible for most skin cancer-related deaths in the United States
(Caple & Holle, 2018). Approximately 4.9 million adults were treated for skin cancer
between 2007 and 2011, with a treatment cost of $8.1 billion in the United States
(American Academy of Dermatology, 2018b). The annual treatment cost for
melanoma is estimated to be $3.3 billion (American Academy of Dermatology,
2018b).
Statistical Significance of
Melanoma in Colorado
According to the Centers for Disease Control and Prevention (2019), the
incidence rate of melanoma was 21.5 per 100,000 people in Colorado with an average
of 1,274 new cases of melanoma in 2016. Out of the new cases of melanoma, there
were about 746 men and 528 women. In 2016, approximately 141 deaths were due to

6

melanoma in Colorado (Centers for Disease Control and Prevention, 2019). The
incidence rate of melanoma was highest among Whites with 23.3 per 100,000 people
and lowest among Hispanics with 5.1 in 2016 (Centers for Disease Control and
Prevention, 2019). The incidence rates of melanoma among White males and White
females were 29.2 per 100,000 people and 18.8 per 100,000 in Colorado in 2016
(Centers for Disease Control and Prevention, 2019). The American Cancer Society
(2018a) estimated there will be 26,800 new cases of melanoma in the state of
Colorado in 2019 with estimated deaths of 8,120. Coloradans are at the highest risk
for melanoma due to ultraviolet radiation with elevation, 300 plus days of sunshine,
and love for outdoors; as a result, the Colorado Melanoma Foundation (2018) ranked
Colorado as one of the highest states for skin cancer incidence and mortality rates.
Melanoma Screening Guidelines
Melanoma is a challenging disease for clinicians to treat due to potential
mortality with delayed recognition and a high incidence of its benign counterpart,
melanocytic nevus (Argenziano et al., 2013). Thus it is essential that melanoma is
identified early so that the appropriate treatment can be identified. There are several
clinical guidelines for melanoma screening; however, those guidelines are not
routinely used in primary care due to inconsistencies among the recommendations for
melanoma in primary care, costs, and time. The U.S. Preventive Services Task Force
(2016) concluded there was insufficient evidence to assess the benefits and harms of
visual skin examination by a clinician for primary- or population-level screening
among asymptomatic adults. However, providers should be aware of the risk factors
of melanoma and any suspicious lesions should be biopsied (U.S. Preventive Services
Task Force, 2016). Other national organizations have their own screening guidelines
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for melanoma such as the American Cancer Society, American Academy of
Dermatology, and Skin Cancer Foundation. However, none of those guidelines
provide a step-by-step approach (algorithm) to identify an at-risk population for
melanoma that is evidence-based, comprehensive, and easy to implement in a primary
care setting.
Risk Prediction Model
for Melanoma
With any pigmentation and lesions on the skin, the diagnosis of melanoma
should be considered. The targeted screening of high-risk individuals for melanoma is
feasible, economical with high specificity, and decreases unnecessary procedures and
patient anxiety as compared to the screening of the entire population (Williams, Shors,
Barlow, Solomon, & White, 2011). To assess the risk of melanoma, there are
prediction models for providers and patients. The risk prediction model can be helpful
at improving the identification of people at high risk for melanoma (Usher-Smith,
Emery, Kassianos, & Walter, 2014).
However, the self- assessment models of melanoma by the patients decrease
the healthcare costs and person power compared to the risk assessment by healthcare
providers. In addition to the self-assessment models for melanoma, other techniques
can be used by healthcare providers such as asymmetry, border irregularity, color that
is not uniform, diameter greater than 6 mm, and evolving size, shape, or the color
(ABCDE) rule; ugly duckling sign; and the Glasgow 7-point checklist.
Self-assessment of melanoma risk score. The self-assessment of melanoma
risk score (SAMScore) was created by the West Melanoma Network that consisted of
a French network of dermatologists, general practitioners, and nurses (Quereux et al.,
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2012). The questions on the risk score were developed using the risk factors
associated with melanoma. It has a total of seven questions: phototype, number of
melanocytic nevi, freckling tendency, severe blistering sunburn during childhood or
teenage years, life in a country at low latitude, a history of previous personal
melanoma, and a history of melanoma in a first degree relative (Quereux et al., 2012).
The questions in the risk score are written in a very simple language so that people
without medical knowledge will be able to comprehend and provide answers to the
questions. The risk score is designed so that the high-risk individuals for melanoma
can be identified (Quereux et al., 2012). Based on the answers, the patients are
identified as high risk or positive SAMScore if at least one of the three criteria is
verified (Quereux et al., 2012). The criteria are listed as follows:





First criterion: Presence of at least three risk factors among the seven
following risk factors i:e phototype I or II, freckling tendency, number
of melanocytic nevi > 20 on both arms, severe sunburn during
childhood or teenage years, life in a country at low latitude, a history of
Previous melanoma, a history of melanoma in a first degree relative.
Second criterion: A patient under 60 years of age and a number of
melanocytic nevi > 20 on both arms.
Third criterion: A patient of 60 years old or over and a freckling
tendency. (Quereux et al., 2012, p. 589)

Mackie scoring system. The Mackie scoring system consists of four
independent risk factors for melanoma such as freckles, moles, atypical nevi, and
history of severe sunburn (Jackson, Wilkinson, Ranger, Phil, & August, 1998). There
are four risk groups based on the questionnaires in the Mackie scoring system:
marginally increased risk, increased risk, very increased risk, and worryingly high risk
(Jackson et al., 1998).
Williams model. This model is a self- assessed clinical risk estimation model
for melanoma that is used to identify people at higher risk for melanoma. The model
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includes seven risk factors: sex, age, natural hair color at age 15 years, number of
severe sunburns aged 2 to18 years, prior nonmelanoma skin cancer, number of raised
moles on both arms, and density of freckles on arms before age 20 (Usher-Smith et al.,
2016). The risk score ranges from 0 to 67 (Usher-Smith et al., 2016).
Brief cancer risk assessment tool. This assessment tool is a self-administered
instrument to assess skin cancer risk. This tool includes risk factors for melanoma and
other keratinocyte skin cancers: ethnicity; personal and family history of skin cancer;
mole count; freckles; childhood residence; sunburn history; and sun sensitivity factors
such as skin color, natural hair color, and ease of sunburn and tanning (Glanz et al.,
2003).
Melanoma risk assessment tool. The melanoma risk assessment tool is an
online assessment tool developed by the National Cancer Institute (n.d.a) for
healthcare professionals to estimate the absolute risk of developing invasive
melanoma. The tool is for non-Hispanic Whites ages 20 to 70 years (National Cancer
Institute, n.d.a). Also, patients with at least one of the diagnoses of melanoma, or
melanoma in situ or non-melanoma skin cancer, and/or a family history of melanoma
should not use this tool to estimate their risk of developing melanoma (National
Cancer Institute, n.d.a). The tool consists of demographics (race, age, location, and
gender), skin characteristics (complexion and sun exposure), and physical exam (size
of moles and freckling tendency) (National Cancer Institute, n.d.a).
Unsupervised self-assessment of melanoma. This tool consists of questions
on melanoma risk factors: skin type, eye color, hair color, total number of nevi,
presence of congenital nevi, skin damage due to solar radiation, history of sunburns,
and family history of melanoma (Harbauer, Binder, Pehamberger, Wolff, & Kittler,

10

2003). Even though the unsupervised questionnaire is helpful in identifying
individuals at high risk for melanoma, it has low accuracy, which limits the
practicability of the questionnaire (Harbauer et al., 2003).
Asymmetry, border irregularity, the color that is not uniform, diameter
greater than 6 mm, and evolving size, shape, or color rule. The ABCDE rule is
widely used by family practice providers while looking at the simple morphologic
appearance of the lesion. The detailed description of the ABCDE rule is below:






A = Asymmetry
Melanoma lesions or moles are not symmetrical and are irregular.
B = Border
Melanoma lesions or mole have irregular borders and are hard to
define.
C = Color
Melanoma lesions or moles have more than one color such as blue,
black, brown, tan.
D = Diameter
Melanoma lesions or moles are greater than 6 mm in diameter.
E = Evolution
Any changes in the color and size of the lesions or moles. (Melanoma
Research Foundation, 2019, para. 3)

The purpose of the rule is to assist providers in distinguishing melanoma from
benign pigmented lesions. The sensitivity (the ability of the test to correctly identify
those with the disease) and specificity (the ability of the test to correctly identify those
without the disease) of the ABCDE rule vary widely depending on the number of
criteria for the specific lesion. Sensitivity and specificity of the ABCDE rule range
from 43% and 99.6%, respectively with all five criteria present and 97.3% and 36%,
respectively with only one criterion present (Herschorn, 2012). Thus people without
melanoma will screen positive for melanoma when all five criteria are used, requiring
unnecessary referrals and biopsies. Furthermore, the opposite is true when only one
criterion is used. Using a rule of all five positive ABCDE criteria is great at
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identifying a melanoma, but there is also a chance that malignant lesions can be
missed if they do not meet all five criteria. Thus the rule is dependent on the
provider’s assessment of the lesions, the provider’s confidence, and the patient’s
ability to explain the changes to the lesions.
Ugly duckling sign. The ugly duckling sign is another clinical approach that
is increasingly popular at identifying a malignant lesion. This approach is based on
the theory that most nevi on an individual’s skin tend to resemble each other, and the
malignant lesions appear different from their neighbors (Herschorn, 2012). This
approach has sensitivity and specificity of 90% and 85%, respectively, even when
used by non-dermatologists (Scope et al., 2008).
Glasgow 7-point checklist. The Glasgow 7-point checklist was developed in
1980 to help non-dermatologists identify the lesions that require further evaluation
with dermatology referral (Walter et al., 2013). The checklist was revised in 1989
with three major and four minor signs of malignant melanoma. The three major signs
include the change in size, shape, and color. The four minor signs include
inflammation, crusting/bleeding, sensory change, and a diameter greater than 7 mm.
The scoring system for this checklist was weighted with two points for major signs
and one point for minor signs and any lesion scoring greater or equal to three
warranted referrals to dermatologists (Walter et al., 2013). A randomized controlled
trial on 1,580 lesions of 1,297 participants from 15 general practices showed that the
weighted 7-point checklist with scores greater and equal to three had the sensitivity of
91.7% and the specificity of 33.1% for melanoma (Walter et al., 2013). The study
also found that the single item of the irregular border had clinically significant
sensitivity and specificity compared to the weighted 7-point checklist at 91.3% and
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92%, respectively (Walter et al., 2013). This also suggests that the revision of a cutoff score from three to greater and equal to four can improve the specificity for the
clinically significant lesions and reduce the unnecessary referrals of the benign lesions
without affecting the sensitivity of melanoma (Walter et al., 2013).
Dermoscope. A dermoscope is a noninvasive optical instrument that can help
providers observe and accurately identify skin lesions that are not visible to the naked
eyes (Zalaudek et al., 2008). It has a hand-held light magnifier with a 10-fold
magnification (Herschorn, 2012). A meta-analysis of studies compared the diagnostic
accuracy of the dermoscope in a clinic setting and compared it to the naked eye
examination (Vestergaard, Macaskill, Holtis, & Menzies, 2008). The analysis
reviewed a total of nine studies of which two studies were randomized controlled trials
and included 8,487 suspicious skin lesions (Vestergaard et al., 2008). The result
showed that the diagnostic odds ratio of the dermoscope was 15.6 times higher than
the naked eye examination and the sensitivity of the dermoscope was 90% as
compared to 71% of naked eye examination (Vestergaard et al., 2008). Furthermore,
the specificity of the dermoscope and naked eye examination did not change,
suggesting that the dermoscope improved the accuracy of identifying melanoma
without increasing the number of misdiagnosed melanomas (Vestergaard et al., 2008).
Another study suggested that the dermoscope resulted in 42% fewer excisions
compared to the naked-eye examination and had a 21% increase in specificity
(Vestergaard et al., 2008).
Despite the diagnostic accuracy of the dermoscope, the use of the device is
much lower in the United States among providers as compared to other countries
(Morris, Alfonso, & Fernandez, 2017). A study was conducted to assess the use of the
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dermoscope among United States providers, practice characteristics, and possible
barriers to dermoscope use. The study recruited 1,466 providers from 49 states in the
United States to complete a brief cross-sectional survey (Morris et al., 2017). The
survey found that only 6% of providers were currently using the dermoscope in their
clinical practice (Morris et al., 2017). Furthermore, 54% of participants had heard of
the dermoscope, 26% had read about it, and only 15% had used it in the past (Morris
et al., 2017). The barriers to incorporating the dermoscope in practice were the cost of
the equipment, time, lack of training, and insufficient reimbursement (Morris et al.,
2017).
Statement of the Problem
Melanoma is on the rise with the increase in the number of mortality and
morbidity rates. The disease can be prevented with early detection and treatment.
There are known environmental and genetic risk factors for melanoma. There are
inconsistent guidelines and recommendations on melanoma screening from several
national and international organizations. Even though the U.S. Preventive Services
Task Force (2016) recommended against routine skin cancer screening, it only applies
to asymptomatic adults without a history of premalignant or malignant skin lesions.
There are several rationales of why skin cancer screening is important. The U.S.
Preventive Services Task Force concluded that increased skin cancer screening may
result in the detection and treatment of basal cell cancer and squamous cell cancer,
impacting life expectancy. According to the American Cancer Society (2019a),
squamous cell cancer causes about 2,000 deaths yearly in the United States. As a
result, early identification of basal cell cancer and squamous cell cancer is a more
valuable benefit than potential harm (Johnson et al., 2017). The U.S. Preventive
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Services Task Force did not include any studies on morbidity associated with
keratinocyte carcinoma and melanoma, which is a critical oversight (Johnson et al.,
2017). Delay in the diagnosis of melanoma can result in thicker melanoma that
requires wider excision, lymph node biopsy, lymph node dissection, and systematic
therapy that can lead to increased morbidity (Johnson et al., 2017).
Furthermore, keratinocyte carcinoma treatments can result in facial
disfigurement and the functional loss with decreased quality of life (Johnson et al.,
2017). The U.S. Preventive Services Task Force (2016) based the recommendation on
the report from Germany’s screen program that screened about 360,288 adults for skin
cancer with 15,983 excisions (Johnson et al., 2017). It was estimated that one per 28
excisions were needed to detect melanoma, which seemed to be an acceptable number
(Johnson et al., 2017). Thus the harm of excision seems to be overestimated by the
U.S. Preventive Services Task Force while formulating the draft for skin cancer
screening (Johnson et al., 2017). There was also a difference in the type of biopsies in
between the screening study from Germany and the United States. In Germany, the
biopsies were fusiform/elliptical excisional biopsies that required deep and superficial
sutures, which is time-consuming and costly with a high morbidity rate as compared to
shaving, cauterization, punch, and/or excision biopsies in the United States (Johnson
et al., 2017). Thus the differences in the types of biopsies were not included while
making the final recommendation by the U.S. Preventive Services Task Force on
melanoma screening, leading to the misinterpretation of procedural data and cosmetic
outcomes (Johnson et al., 2017). One study showed a two times higher likelihood of
thinner melanoma being diagnosed with a skin examination by a provider and four
times higher likelihood in men over age 60 years (Swetter, Pollitt, Johnson, Brooks, &
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Geller, 2012). The study was excluded due to its retrospective study design by the
panel members of the U.S. Preventive Services Task Force. Furthermore, there was a
reduction of 69% in the incidence of melanoma and decreased mortality of melanoma
with education, intervention, and screening programs at the Lawrence Livermore
National Laboratory in Northern California (Schneider, Moore, & Mendelsohn, 2008).
This study was excluded by the panel members of the U.S. Preventive Services Task
Force because of the lack of generalizability to primary care (Johnson et al., 2017).
No dermatology expert was on the panel of the U.S. Preventive Services Task Force
who developed the guideline for skin cancer screening (Johnson et al., 2017).
There are several melanoma self-assessment tools such as SAMScore, Mackie
model, Williams model, brief cancer risk assessment tool, melanoma risk assessment
tool, and unsupervised self-assessment tool. In addition, techniques exist for providers
to assess a lesion for melanoma and they are the ABCDE rule, ugly duckling sign,
Glasgow 7-point scale, and dermoscope. Each tool and technique has strengths and
limitations; however, there is a lack of a standardized tool and technique for
melanoma screening in the primary care settings.
Even though providers are aware of the importance of melanoma screening, it
is not routinely performed in the United States. Barriers have been identified to
effective melanoma screening in primary care. Some of the major reasons for the lack
of skin cancer screening in primary care include lack of confidence among primary
care providers, low priority for skin cancer screening, lack of reimbursement, lack of
standardized guidelines, time constraints, patient embarrassment, distraction by other
health problems, and the perception that most of the screenings do not result in
significant findings (Jiang et al., 2017; Oliveria, Heneghan, Cushman, Ughetta, &
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Halpern., 2011). It is very important that the barriers be addressed and resolved to
solve the lack of inconsistency regarding melanoma screening. About two-thirds of
medical students and three-fourths of primary care residents felt they did not have
adequate training in a total body skin examination (Johnson et al., 2017). The
National Health Interview Survey showed that only 8% of patients were screened for
melanoma by their primary care providers or obstetrician/gynecologist within the last
12 months (Johnson et al., 2017). There is a very low screening rate for melanoma at
16% for men and 13% for women compared to 51% for colorectal, 54% for breast
cancer, and 43% for prostate cancer (Johnson et al., 2017).
Historically, the detection of melanoma heavily relied on full-body skin exams
by dermatologists. However, in spite of a notable increase in the incidence of
melanoma, there has not been a rapid increase in the number of dermatologists in the
United States. According to Schember (2015), only 13,847 dermatologists are in the
United States, which is equivalent to a mere 1% of providers. During a four-year
period from 2010 to 2014, there was only a 10% increase in the number of
dermatologists in the United States (Schember, 2015). With the limited number of
dermatologists, it is impossible for dermatologists to evaluate all skin conditions in a
timely fashion. Primary care providers are the first providers that many patients with
suspicious skin lesions will seek in a community (Fleming, Grade, & Bendavid, 2018).
About 41.8% of all the annual office visits are to a family practitioner or internist in
the United States (Oliveria et al., 2011). Thus primary care providers play an essential
role in the early detection of melanoma by performing diagnostic biopsies of
suspicious skin lesions or referring patients to dermatologists for further evaluation
(Fleming et al., 2018).
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Thus a standardized evidence-based and comprehensive melanoma screening
tool or technique is needed that can be utilized by primary care providers to screen
individuals at high-risk for melanoma. Education regarding melanoma screening is
needed among primary care providers and the general population. It is very important
that barriers identified by primary care providers be addressed and resolved to solve
the lack of inconsistency regarding melanoma screening.
Purpose of the Project
The burden of melanoma screening relies heavily on primary care providers
due to the inadequate number of dermatologists in the United States. However,
primary care providers do not perform melanoma screening due to time constraints,
lack of training, lack of standardized guidelines, and the complexity of a patient’s
medical issues. The purpose of this scholarly project was to implement an evidencebased melanoma screening algorithm using SAMScore to identify patients at high risk
for melanoma in a primary care setting by primary care providers in an effort to
facilitate early detection and initiate treatments to minimize the complications related
to melanoma. The SAMScore was chosen over the other assessment tools and
techniques because it is a validated assessment tool for healthcare providers at
identifying high-risk patients for melanoma, and it requires 11.54 times fewer patients
to detect a new case of melanoma as compared to a non-targeted screening (Quereux
et al., 2012).
Patient Population, Intervention, Comparison/
Intervention, Outcome Question, and Time
Primary care providers play an important role in the identification of patients
who are at high risk for melanoma. Even though the primary screening for melanoma

18

for the general population is not recommended by the U.S. Preventive Services Task
Force (2016), a targeted melanoma screening has been recommended to identify highrisk patients for melanoma for early diagnosis and survival (Curiel-Lewandroski,
Chen, & Swetter, 2013). Melanoma is a curable disease if diagnosed early, and the
people at high-risk are not routinely screened for this disease which is a major
problem. Since the SAMScore is a validated tool, this tool was utilized to screen highrisk patients for melanoma in this scholarly project. Also, an evidence-based
algorithm was developed by the project lead. The patient population, intervention,
comparison/intervention, outcome, and time (PICOT) question format was used to
develop the clinical question in the evidence-based quality improvement project. Thus
the following PICOT question was developed by the project lead to assess if the
algorithm yielded an increase in the number of melanoma screening for high-risk
patients by the primary care providers in a primary care setting.
Q1

In English speaking adult patients (ages 35 to 75 years), attending
annual wellness visits in a primary care setting, how does the use of a
melanoma screening algorithm for providers including riskstratification questionnaire, compared with usual practice (no provider
workflow, algorithm, or structured screening recommendation) affect
identification of patients at high-risk of melanoma (and therefore
likelihood of future evidence-based clinical interventions of skin cancer
diagnosis and treatment) during a one-month intervention period as
compared to one-month pre-intervention period in the same practice?
Definition of Terms

Familial atypical multiple mole melanoma syndrome. It is an autosomal dominant
genodermatosis characterized by multiple melanocytic nevi (more than 50) and
a family history of melanoma (Mize, Bishop, Resse, & Sluzevich, 2009). It is
associated with the mutation of the CDKN2A gene.
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Incidence rate. The ratio of the number of new cases to the total time the population is
at risk of disease (Centers for Disease Control and Prevention, 2012).
Metastasis. The spread of the cancer cells from where they first formed to another
part of the body (National Cancer Institute, n.d.b).
Odds ratio. The odds that an outcome will occur given an exposure compared to the
odds of the outcome occurring in the absence of that exposure (Szumilas,
2010).
Sensitivity. The ability of a test to correctly classify an individual as diseased (Parikh,
Mathai, & Thomas, 2008).
Specificity. The ability of a test to correctly classify an individual as disease-free
(Parikh et al., 2008).
Xeroderma pigmentosum. An inherited condition characterized by an extreme
sensitivity to ultraviolet rays from sunlight (National Institutes of Health,
2019).
Conclusion
Complications of melanoma can be prevented with early diagnosis and
treatment. Primary care providers are in an optimal position to screen patients at high
risk for melanoma. Consensus on the melanoma screening guidelines is lacking in the
United States. An evidence-based melanoma screening model or tool or algorithm can
be helpful to primary care providers so they can identify patients at high risk for
melanoma. The appropriate intervention can then be initiated for patients identified as
high risk.
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CHAPTER II
REVIEW OF LITERATURE
Synthesis of the Literature
The literature review was conducted on melanoma, historical background on
melanoma, melanoma screening guidelines from national and international agencies,
melanoma screening tools and techniques, barriers to melanoma screening by
providers, interventions to melanoma screening, time to perform melanoma screening
with and without a dermoscope, and targeted age group for melanoma screening. The
following electronic databases were utilized for the literature review: Academic
Search Premier, Cochrane Central Register of Controlled Trials, Cochrane Database
Systematic Review, Google Scholar, PubMed, and ScienceDirect. Keywords included
in the search were melanoma screening, primary care, skin cancer screening, cancer
screening, melanoma screening guideline, and melanoma screening criteria. Criteria
included full-text articles published between 1998 and 2019 and written in the English
language. The study types were randomized controlled trials, systematic reviews,
meta-analysis studies, retrospective studies, and cohort studies.
Historical Background
The word melanoma is derived from the Greek word “melas” meaning dark
and “oma” meaning tumor (Rebecca, Sondak, & Smalley, 2012). The description of
melanoma first appeared in the literature in the writings of Hippocrates of Cos in the
fifth century B.C. and again in the Greek physician Rufus of Eupheses (Rebecca et al.,
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2012). The word melanoma was coined by Sir Robert Carswell in 1838 (Rebecca et
al., 2012). The first surgical removal of melanoma was done by the Scottish surgeon
John Hunter at St George’s Hospital Medical School in London, and it was performed
on a recurrent melanoma on the jaw of a 35-year-old man (Rebecca et al., 2012). At
that time, the surgeon did not know what he was removing. Thus the tumor was
preserved and was later diagnosed as melanoma in 1968 (Rebecca et al., 2012). The
melanoma is housed in the Hunterian Museum at Lincolns Inn Fields in London
(Rebecca et al., 2012).
The physical evidence of melanoma was first seen in the skeletons of PreColombian mummies (2,400 years old) from Chancay and Chingas in Peru (Rebecca
et al., 2012). In 1820, Dr. William Norris published a report on the etiology and
progression of melanoma based on a study he conducted on a 59-year-old male patient
with melanoma over three years until the man passed away (Rebecca et al., 2012).
During the study, he found several reddish and whitish brown tints throughout the
body (Rebecca et al., 2012). He also found several spots of various sizes inside the
abdomen of the man upon autopsy and noted that the man’s father passed away due to
a similar disease (Rebecca et al., 2012). After an in-depth study of the case, he
concluded that the disease was hereditary in nature (Rebecca et al., 2012). In 1857, he
studied eight other cases of melanoma and proposed the relationship of melanoma
with nevi and environmental factors (Rebecca et al., 2012). In 1837, Isaac Parish
documented the first North American case of melanoma where he described
melanoma as “a purple mark or mole about the size of a mulberry” (Rebecca et al.,
2012, p. 116).
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Types of Melanoma
There are four categories of melanoma: superficial spreading melanoma,
lentigo melanoma, acral lentiginous melanoma, and nodular melanoma.
Superficial spreading melanoma. This is the most common type of
melanoma, accounting for almost 70% of all melanomas (Skin Cancer Foundation,
2019). This type of melanoma first appears as a flat or slightly raised, discolored
patch with irregular borders and travels along with the top layer of skin before
extending deep into the skin (Aim at Melanoma Foundation, 2014c; Skin Cancer
Foundation, 2019). These lesions commonly appear on the trunks of men, legs of
women, and upper back of both sexes (Aim at Melanoma Foundation, 2014c). They
are usually diagnosed in patients between the ages of 30 and 50 years. Half of this
type of melanoma occurs in pre-existing moles (Aim at Melanoma Foundation,
2014c). The color varies from tan, brown, black, red, blue, or white.
Lentigo melanoma. A lentigo melanoma is a subtype of melanoma in situ,
which is more commonly found in chronically sun-damaged skin and can progress to
become invasive melanoma (Skin Cancer Foundation, 2019). About 5% of all
melanomas are lentigo melanoma (Aim at Melanoma Foundation, 2014c). This
melanoma is generally large, flat, and tan color, but can be black, blue, red, gray, or
white and typically takes years to develop (Aim at Melanoma Foundation, 2014c).
This melanoma is common in older adults on the face and other chronically sunexposed areas (Aim at Melanoma Foundation, 2014c).
Acral lentiginous melanoma. Acral lentiginous melanoma is a type of
melanoma that stays on the surface of the skin superficially before penetrating the
deep tissue layers (Skin Cancer Foundation, 2019). The term acral comes from the
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Greek word “akron,” which means extremity (Aim at Melanoma Foundation, 2014c).
Thus this melanoma usually appears as a black or brown discoloration under the nails
or soles of feet or palms of hands (Skin Cancer Foundation, 2019). About 2% to 3%
of all melanomas are acral lentiginous melanoma (Bradford, Goldstein, McMaster, &
Tucker, 2009). It is most common in African Americans and Asians and is the least
common type of melanoma diagnosed among Caucasians (Skin Cancer Foundation,
2019). It is difficult to diagnose early because it appears like a bruise or injury to the
palms, soles, or nail beds (Aim at Melanoma Foundation, 2014c).
Nodular melanoma. Nodular melanoma is a type of melanoma that is usually
invasive and aggressive by the time it is first diagnosed (Skin Cancer Foundation,
2019). It first appears as blue-black, dome-shaped nodule on legs, arms, trunk, and
scalp (Skin Cancer Foundation, 2019). It accounts for approximately 10% to 15% of
cases (Skin Cancer Foundation, 2019). Thus the prognosis of the nodular melanoma is
poor compared to other melanomas (Aim at Melanoma Foundation, 2014c).
Summary. Melanoma varies in its color, penetration, appearance, and
exposure. There are four different types of melanoma. As a provider, it is important
to have knowledge on all types of melanoma so that melanoma can be diagnosed as
early as possible and appropriate intervention can be performed in a timely manner
before the disease metastasizes to other parts and organs of the body.
Stages of Melanoma
It is important for primary care providers to understand the various stages of
melanoma as it helps them to determine treatment options and prognosis. The
American Joint Commission on Cancer has recommended a melanoma staging system
that ranges from 0 through stage IV (Aim at Melanoma Foundation, 2014b). If the
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staging number is lower, it means the melanoma has not spread or is localized. As the
number increases, it means that the melanoma has spread or metastasized to other
parts or organs of the body.
Stage 0 melanoma. This is the stage of melanoma where the tumor is only on
the epidermis layer of the skin and has not grown deeper invading surrounding tissues
or lymph nodes or distant sites (Aim at Melanoma Foundation, 2014b). Patients with
this stage of melanoma are at lower risk for local recurrence or regional or distant
metastases of the disease (Aim at Melanoma Foundation, 2014b). This melanoma is
also called melanoma in situ.
Stage I melanoma. Stage I melanoma is differentiated into subclasses IA and
IB. Stage IA melanoma is melanoma with no more than a 1 mm thickness and may or
may not have ulceration (National Cancer Institute, 2019). Stage IB is melanoma with
more than a 1 mm thickness, but no more than a 2 mm thickness and without
ulceration (National Cancer Institute, 2019). There is no evidence the tumor has
spread to lymph nodes or metastasize to distant sites, and patients with stage I are at a
lower risk for local recurrence of regional or distant metastases (National Cancer
Institute, 2019).
Stage II melanoma. Stage II melanoma is differentiated in subclasses IIA,
IIB, and IIC. Stage IIA is melanoma with a 1 to 2 mm thickness with ulceration or a 2
to 4 mm thickness without ulceration (National Cancer Institute, 2019). Stage IIB is
melanoma with a 2 to 4 mm thickness with ulceration of more than a 4 mm thickness
without ulceration (National Cancer Institute, 2019). Stage IIC is melanoma with
more than a 4 mm thickness with ulceration (National Cancer Institute, 2019).
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Stage III melanoma. Stage III melanoma is differentiated into four
subclasses: IIIA, IIIB, IIIC, and IIID. Stage IIIA melanoma is less than 1 mm in
thickness with ulceration or between a 1 to 2 mm thicknesses without ulceration
(National Cancer Institute, 2019). This melanoma is found in one to three lymph
nodes by sentinel lymph node biopsy and has microsatellite tumors (tumor cells beside
or below the primary melanoma that can be seen with a microscope), satellite tumors
(tumor cells within 2 cm of the primary melanoma that can be seen without a
microscope), and/or in-transit metastases (type of metastasis where cancer spreads
through lymph vessels and grows within 2 cm from the primary melanoma) on or
under the skin (National Cancer Institute, 2019). Stage IIIB has three criteria. First
criteria stage IIIB is melanoma when the primary tumor cannot be visualized by the
naked eye and the melanoma is found in one lymph node by a physical exam or
imaging tests (National Cancer Institute, 2019). The second criterion stage IIIB is
melanoma less than 1 mm thick with ulceration or between 1 to 2 mm thick without
ulceration with one to three lymph nodes of involvement (National Cancer Institute,
2019). Third criteria stage IIIB is melanoma between 1 to 2 mm thick with ulceration
or between 2 to 4 mm thick without ulceration and one to three lymph nodes of
involvement (National Cancer Institute, 2019). Stage IIIC has four criteria. First
criteria stage IIIC melanoma cannot be seen with the naked eye and is found in two or
three lymph nodes or one to four or more lymph nodes with microsatellite tumors,
satellite tumors, and/or in-transit metastases on or under the skin (National Cancer
Institute, 2019). Second criteria stage IIIC is less than 2 mm thick with or without
ulceration or more than 4 mm without ulceration and found in more than four lymph
nodes or one to four lymph nodes with microsatellite tumors, satellite tumors, and/or
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in-transit metastases on or under the skin (National Cancer Institute, 2019). The third
criterion stage IIIC melanoma is between 2 and 4 mm thick with ulceration or more
than 4 mm thick without ulceration (National Cancer Institute, 2019). This is found in
one or more lymph nodes. The fourth criteria stage IIIC melanoma is more than 4 mm
thick with ulceration and found in one or more lymph nodes (National Cancer
Institute, 2019). Stage IIID melanoma is more than 4 mm thick with ulceration and
found in more than two lymph nodes (National Cancer Institute, 2019).
Stage IV melanoma. This is the stage of melanoma where melanoma has
metastasized to lymph nodes distant from the primary site and spread to internal
organs such as the liver, brain, bone, and gastrointestinal tract (National Cancer
Institute, 2019). The prognosis of this melanoma is poor.
Summary. The stages of melanoma are a great method to understand the
progression of the disease. Understanding the stages of melanoma helps a provider
formulate a treatment plan and educate the patient on their disease. It also helps in the
diagnosis of melanoma and determines the prognosis of the disease.
Melanoma Genetics
Genes exist that predispose a person to melanoma and those genes are divided
into low, medium, and high penetrance genes. The penetrance of a gene refers to the
“likelihood of a mutation carrier developing the disease over time and reflects the
overall contribution of specific gene polymorphism, or mutation to a melanoma risk”
(Read, Wadt, & Hayward, 2015, p. 1). The high penetrance genes include cyclindependent kinase inhibitor 2A (chromosome 9p21), cyclin-dependent kinase 4
(chromosome 12 q14), BRCA1-assocaited protein-1 (tumor suppressor gene on
chromosome 3p21), protection of telomeres 1 (gene that protects telomeres),
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adrenocortical dysplasia protein homolog/telomeric repeat binding factor 2 interacting
protein (regulates telomere length), and telomerase reverse transcriptase (catalytic
subunit of telomerase) (Read et al., 2015). The medium penetrance genes include
melanocortin 1 receptor gene (encodes G-protein coupled receptor that binds alphamelanocyte stimulating hormone), microphthalmia-associated transcription factor (key
regular of pigment cells including development and differentiation of melanocytes),
and solute carrier family 45, member 2 variants (protective against melanoma and
associated with darker skin) (Read et al., 2015). There are several low penetrance
genes for melanoma; however, some of the common low penetrance genes include
Agouti signaling protein, tyrosinase, tyrosinase-related protein 1, and oculocutaneous
albinism type II (Read et al., 2015). Even though no single gene can guarantee
melanoma development, presence of those genes places an individual at higher risk for
melanoma. It is likely that people with moderate to high genetic susceptibility require
fewer somatic mutations before the development of melanoma (Read et al., 2015). In
addition, melanoma risk genes may directly or indirectly interact with the other genes
or environmental risk factors to influence and activate melanoma growth pathways
(Read et al., 2015). However, the genetic testing of melanoma remains controversial
due to the low frequency of high penetrance mutations and a combination of multiple
other risk factors besides genes that can increase a patients’ risk for melanoma (Read
et al., 2015).
Melanoma Screening Guidelines
U.S. Preventive Services Task Force melanoma screening guideline. The
U.S. Preventive Services Task Force (2016) concluded that the current evidence is
insufficient to assess the balance of benefit and harm of visual skin examination by a
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clinician to screen for skin cancer in adults. The rating for the grade is “I” which
means that the current evidence is lacking or of poor quality or conflicting to make the
recommendation for the service. However, the recommendation only applies to
asymptomatic adults without a history of premalignant or malignant skin lesions.
Patients with suspicious skin lesions or those under surveillance due to a high risk for
skin cancer, such as familial syndrome, are outside the scope of this recommendation
statement (U.S. Preventive Services Task Force, 2016). Risk factors to melanoma,
such as male gender, fair complexion, indoor tanning beds, personal history of
sunburns or previous skin cancer, dysplastic nevus, multiple nevi, family history of
melanoma, and advanced age require clinical consideration (U.S. Preventive Services
Task Force, 2016). The U.S. Preventive Services Task Force recommended assessing
skin lesions using the asymmetry, border irregularity, color that is not uniform,
diameter greater than 6 mm, and evolving size, shape or color (ABCDE) rule. The
screening interval for melanoma is unknown. The treatment of melanoma after the
detection includes excision with or without lymph node management (U.S. Preventive
Services Task Force, 2016).
American Academy of Dermatology. The American Academy of
Dermatology (2018a) recommended that high-risk individuals perform regular selfexams to detect skin cancer early and seek an annual full-body exam. The Academy
encourages the general population to perform regular self-skin exams since about half
of the melanomas are self-detected (American Academy of Dermatology, 2018b).
Ultraviolet radiation is the most preventable risk factor for all skin cancers; thus the
Academy recommends that everyone avoid indoor tanning beds, avoid ultraviolet rays
by seeking shade, wear protective clothing, and use a broad-spectrum water-resistant

29

sunscreen with a sun protection factor of 30 or higher (American Academy of
Dermatology, 2018a).
American Cancer Society. The American Cancer Society recommends
cancer screening including a skin exam every three years in patients between the ages
of 20 and 40 years and yearly screening in patients older than 40 years (Zoorob,
Anderson, Cefalu, & Sidani, 2001). High-risk individuals for skin cancer should have
regular skin exams as determined by their healthcare provider (American Cancer
Society, 2018b). The skin exam recommendation varies by the provider and the
number of risk factors to skin cancer (American Cancer Society, 2018b).
American Academy of Family Physicians. The American Academy of
Family Physicians published a statement in 2009 stating,
There is insufficient evidence to assess the balance of benefits and harms of
using the whole-body skin examination by a primary care provider or patient
skin self-examination for the early detection of cutaneous melanoma, basal cell
carcinoma or squamous cell carcinoma in the adult general population.
(Johnson et al., 2017, p. 23)
Other organizations and associations. The American Medical Association
recommends an annual skin examination in patients at moderate risk for skin cancer
and advises patients to discuss the frequency of skin cancer screening with their
providers and perform skin self-examinations monthly (Zoorob et al., 2001). The
Canadian Task Force on Preventive Health Care (2018) agreed with the U.S.
Preventive Services Task Force (2016) that insufficient evidence exists to recommend
routine skin screening by primary care providers in low-risk patients and is a grade C
recommendation. However, the Canadian Task Force on Preventive Health Care
recommended that providers counsel their patients on reducing sun exposure by using
sunscreen and wearing protective clothing. Thus there is an inconsistency among
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several organizations regarding skin cancer screening guidelines and
recommendations.
Summary. The various national and international organizations differ from
each other with the recommendation for skin cancer or melanoma screening. Some
guidelines have recommendations for people with low, moderate, and high risk for
melanoma; however, the guidelines are not clear on what the low, moderate, and high
risk for melanoma entail. While the risk factors of melanoma are listed by the U.S.
Preventive Services Task Force (2016), other organizations do not list the risk factors
for melanoma. There is variability among risk factors as determined by the
organization. There is inconsistency in the age group and frequency of melanoma
screening. Even though there are differences and inconsistencies among the
recommendations for melanoma screening, the organizations agree that high-risk
patients need frequent melanoma screening and interventions, such as dermatology
referral and education on ways to prevent melanoma such as clothing and sunscreen.
Thus the above inconsistencies clearly show there is a need for a standardized method
to identify patients who are at high-risk for melanoma.
Risk Prediction Models
for Melanoma
Self-assessment of melanoma risk score. The survival due to melanoma is
inversely related to the thickness of the melanoma at the time of diagnosis; thus early
diagnosis is a key for improving the prognosis of patients with melanoma (Quereux et
al., 2012). Mass screening for melanoma is not recommended due to higher costs and
lower chances of finding melanomas (Quereux et al., 2012). Instead, the targeted
screening is recommended to identify patients at high risk for melanoma. A
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prospective study was performed to assess the feasibility and validity of the selfassessment risk factor of melanoma, also known as the self-assessment of melanoma
risk score (SAMScore) among 46 general practitioners in the city of Nantes in the
Pays de Loire region located in the west of France (Quereux et al., 2012). Nantes is a
big town with people of all skin types (Quereux et al., 2012). Patients older than 18
years were asked to fill out the SAMScore independently prior to being seen by the
provider. Approximately 7,953 patients completed the SAMScore. Among the total
sample population, 2,404 patients had at least one of the three criteria of the
SAMScore verified and were identified as high-risk patients for melanoma (Quereux
et al., 2012). Patients were considered high-risk for melanoma if they met one of the
criteria of the SAMScore. For those who were identified as being at high risk for
melanoma, providers performed a whole-body skin exam, and patients with suspicious
lesions were then referred to dermatologists for further evaluation and biopsy as
needed (Quereux et al., 2012). Among 2,404 high-risk patients, 10 melanomas were
detected (Quereux et al., 2012). Thus the efficiency of the SAMScore was 11.54
using the logistic model with a random effect, which means that the SAMScore was
11.54 more efficient in detecting a new case of melanoma as compared to a nontargeted screening tool (Quereux et al., 2012). For the patients who did not meet the
criteria for the SAMScore, they were not examined by the providers, which may have
resulted in false negatives for the study (Quereux et al., 2012).
A randomized controlled trial was done on the French west coast to assess the
effect of a targeted melanoma prevention intervention on patient prevention behaviors.
The targeted population for the study was patients at high risk for melanoma as
determined by the SAMScore with a relative risk of 11 times higher than the general
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population (Rat et al., 2014). A total of 20 general providers and 470 patients
participated in the study. Prior to the study, the providers reviewed an e-learning
module on melanoma screening and skin exams. Half of the providers were given
access to the SAMScore algorithm as the intervention group, and the other half did not
have access to the SAMScore (Rat et al., 2014). All patients were given a SAMScore
questionnaire to complete while they were waiting in the waiting area regardless of the
type of visit (Rat et al., 2014). In the intervention group, providers utilized the
SAMScore risk calculator to determine if the patient was at high risk for melanoma
(Rat et al., 2014). For patients who were identified as high risk, providers performed a
total skin examination, counseled the patient, and gave the information leaflet on
primary and secondary prevention measures (Rat et al., 2014). However, the control
providers provided the information leaflet only.
The study suggested that the multifaceted approach by the general providers of
identifying patients at risk, performing skin examinations, giving advice, and handing
printed information on the prevention of melanoma had a great impact on patients
compared to handing printed information alone. Based on the intervention, patients in
the intervention group were better able to recognize the risk factors to melanoma
(71.1% versus 42.1%), more likely to perform a skin self-exam during the past 12
months (52.6% versus 36.8%), and less likely to sunbathe during the summer (24.7%
versus 40.8%) (Rat et al., 2014).
Mackie scoring system. A case-control study was conducted by the Scottish
Melanoma Group and Scottish Cancer Registry in 1987 to identify if clinically
significant risk factors predicted the risk of invasive cutaneous melanoma (Mackie,
Freudenberger, & Aitchison, 1989). The total sample population was 371 patients
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who were diagnosed with invasive cutaneous melanoma. Patients were interviewed
about their personal history of melanoma, history of melanoma in first degree
relatives, previous residence in tropical or subtropical climates, episodes of severe
sunburn, and use of artificial sources of ultraviolet radiation (Mackie et al., 1989).
Patients were also examined for the number of melanocytic nevi greater than 2 mm in
diameter, atypical nevi, and freckling tendency (Mackie et al., 1989). Each risk factor
was calculated for the relative risk using logistic regression analysis. Based on the
results, the total number of nevi was the most important risk factor (Mackie et al.,
1989). Also, atypical nevi were present in 36% of men and 39% of females who had
melanoma (Mackie et al., 1989). Sixteen percent of patients had three or more
atypical nevi compared to 1% who did not have melanoma (Mackie et al., 1989).
Furthermore, 48% of women and 52% of men with freckles had melanoma (Mackie et
al., 1989). Nineteen percent of melanoma patients had a history of three or more
episodes of severe sunburn (Mackie et al., 1989). Thus the relative risk was calculated
for each of the risk factors and found major risk factors: total number of nevi, number
of atypical nevi, freckling tendency, and number of episodes of severe sunburn
(Mackie et al., 1989). The selection of variables for the personal risk chart used a
forward stepwise approach based on a conditional logistic regression model, where the
model tends to underestimate the true relative risk of melanoma from the presence of
three or more atypical nevi and three or more episodes of severe sunburn (Mackie et
al., 1989). Thus even though the relative risk of the Mackie model is an acceptable
guide to the magnitude of the risk, it may underestimate the relative risk in extreme
cases of melanoma (Mackie et al., 1989). Also, the model was tested among a small
sample population of 371 patients with invasive cutaneous melanoma.
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Williams model. A study was conducted to create a melanoma risk score
based on self-assessed risk factors and determine the odds ratio for each risk factor for
melanomas (Williams et al., 2011). Data were collected from a case-control study of
melanoma from Washington State (Williams et al., 2011). A total of 1,113 sample
population with 386 cases and 727 controls aged 35 to 74 years were interviewed via
telephone (Williams et al., 2011). There were several variables for the model: sex,
age, education, income, marital status, tendency to sunburn, ability to tan, number of
severe sunburn from ages 2 to 18, natural hair color at age 15, density of freckles on
arms before age 20, number of raised moles on both arms, prior mole removal, number
of moles removed, and prior non-melanoma skin cancer (Williams et al., 2011). A
multivariate model was generated to predict the risk factors for invasive melanoma
(Williams et al., 2011). In the final model there were only seven risk factors: age,
male sex, number of severe sunburns from ages 2 to18, natural hair color at age 15,
density of freckles on the arms before age 20, number of raised moles on both arms,
and prior non-melanoma skin cancer remained significant (Williams et al., 2011). The
validated area under the curve for the Williams model was 0.70, which indicated that
the model predicts melanoma moderately well (Williams et al., 2011).
Brief cancer risk assessment tool. A study was conducted to develop and
pilot the brief cancer risk assessment tool. The tool was developed after critically
reviewing the literature on the risk factors and self-assessment for melanoma and basal
cell and squamous cell cancer (Glanz et al., 2003). The risk factors included personal
and family history of skin cancer, total body mole count, freckles, childhood
residence, sunburn history ethnicity, and sun sensitivity factors (Glanz et al., 2003).
The study consisted of two pilot studies. The first pilot study included administering
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the questionnaire to 173 patients between the ages of 20 and 65 and without skin
cancer (Glanz et al., 2003). The same questionnaire was administered to those
patients again one month later via telephone (Glanz et al., 2003). The second pilot
study included sending a mailed packet to 165 patients who were considered at
moderate to high risk based on the brief risk assessment tool on their sun habits and
sun exposures (Glanz et al., 2003). The relative risk was calculated for each of the
risk factors and ranged from 0.57 to 0.97. Thus the tool was considered an acceptable
tool for skin cancer assessment, but the validation of the tool with a clinical exam
would have been useful (Glanz et al., 2003). Also, the tool did not include a family
history of melanoma as one of the risk factors, which was a limitation of the tool
(Glanz et al., 2003). Marlene
Melanoma risk assessment tool. A melanoma risk assessment tool was
developed from a case-control study with 1,663 non-Hispanic White patients in a
clinic from Philadelphia, Pennsylvania, and San Francisco, California (National
Cancer Institute, n.d.a). The tool calculated the absolute risk of the patients in
developing invasive melanoma (National Cancer Institute, n.d.a). The tool consisted
of questions on race, age, location, gender, complexion, sun exposure, moles, and
freckling tendency (National Cancer Institute, n.d.a). The tool is available free of cost
to the general public and providers but recommends discussing the results of the tool
with a provider after it is completed (National Cancer Institute, n.d.a). This tool is
only for screening and surveillance for melanoma and is not recommended to use for
patients with current melanoma, melanoma in situ, non-melanoma skin cancer, and
family history of melanoma (National Cancer Institute, n.d.a). Also, the tool is not
validated to be used for all non-Hispanic Whites (National Cancer Institute, n.d.a).
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Unsupervised self-assessment of melanoma. A case-control study was
conducted to validate the unsupervised self-assessment of melanoma risk at the
Department of Dermatology in Vienna (Harbauer et al., 2003). A total of 222 patients
had confirmed cases of primary melanoma and 220 control patients (National Cancer
Institute, n.d.a). Questions were administered to all participants with melanoma risk
factors such as skin type, eye color, hair color, total number of nevi, presence of
congenital nevi, skin damage from solar radiation, history of sunburns, and family
history of melanoma (National Cancer Institute, n.d.a). After the questions were filled
out, every patient was examined by a dermatologist. The self-assessment of risk
factors and physician assessment of the risk factors were compared. The areas under
the curve for self-assessment and physician assessment were 0.73 and 0.77,
respectively (National Cancer Institute, n.d.a). The self-assessment was able to
identify 39% of high- risk patients, and the physician assessment was able to identify
42% of high-risk patients for melanoma (National Cancer Institute, n.d.a). Even
though the self-assessment tool was moderately valid at identifying the high-risk
patients for melanoma, the location of the study, which was the dermatology clinic,
limited the accuracy of the tool since most patients in a dermatology clinic may be at
high risk for melanoma anyways (National Cancer Institute, n.d.a).
Summary. All the studies on the risk prediction model had limitations and
strengths. The study on the Mackie scoring system was based on a very small sample
population underestimating the relative risk of each risk factor. The study on the
Williams model was administered via telephone to patients who were diagnosed with
melanoma; thus the answers may not have been accurate since the questions were
asked by the researchers and not done by the patients themselves. The brief
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assessment tool was not validated among the non-Hispanic population since the
sample size was small for the validation study. The melanoma screening tool was an
online tool and may not be feasible to use for those with limited computer knowledge.
The unsupervised self-assessment tool was only moderately valid, and the location of
the study limited the generalizability and result of the study. Thus the SAMScore was
chosen as the risk prediction model for this scholarly project since the validation study
had a large sample population of 7,953, and the self-assessment questionnaire was
followed by the primary care providers and dermatologists as needed. Furthermore,
the SAMScore was 11.54 times more efficient in detecting a new case of melanoma.
Barriers to Melanoma Screening
A randomized survey was done to determine barriers and facilitating factors to
full body skin exams among dermatologists and primary care providers. The sample
for the study was randomly selected from the American Medical Association medical
marketing services database that included more than 30,000 office-based practicing
providers (Oliveria et al., 2011). Providers were categorized as family practitioners,
internists, and dermatologists. There were two modes of data collection: a mixedmode (electronic and postal mail survey) and an entirely postal mail survey (Oliveria
et al., 2011). The survey instrument consisted of 13 questions on demographics,
practice characteristics, skin cancer screening behaviors, and barriers and facilitators
to performing full-body skin exam (Oliveria et al., 2011). Barriers to skin cancer
screening included lack of skill or training, uncertainty about what to look for, time
constraints, lack of proper equipment, patient embarrassment, not routinely doing skin
assessment, lack of or inadequate reimbursement, low probability of finding cancer,
lack of importance of skin examination, lack of standardized guidelines, low risk
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patients for melanoma, and presence of competing comorbidities (Oliveria et al.,
2011). Facilitators of performing a full-body skin exam include skill or expertise in
performing an exam and diagnosing skin cancer, influence of medical training, high
risk patients, patient demand, adequate reimbursement, medicolegal pressure to
perform preventive procedures, completeness of patient records, and evidence
supporting skin examination as a tool for skin cancer prevention (Oliveria et al.,
2011). The questions were graded on a 4-point scale ranging from not a factor (1) to
major (4).
Out of 2,999 providers, only 1,669 providers were included in the survey with
an overall rate of 59.2% (Oliveria et al., 2011). Of all the respondents, more than twothirds of the providers stated they perform a full-body skin exam during a complete
physical examination (Oliveria et al., 2011). The full-body skin exam rates for
dermatologists, family practitioners, and internists were 81.3%, 59.6%, and 56.4%,
respectively (Oliveria et al., 2011). The top three barriers among all disciplines were
time constraints, competing comorbidities, and patient embarrassment or reluctance
(Oliveria et al., 2011). The top three facilitators included patients at high risk, patient
demand for complete examination or mole checks, and the influence of medical
training (Oliveria et al., 2011).
One of the most common barriers to a full body skin exam, as reported by
primary care providers, was time (Oliveria et al., 2011). Zalaudek et al. (2008) formed
a randomized multicenter study to determine the actual time required to perform a fullbody skin exam with and without a dermoscope. There were a total of 1,359 patients
from eight clinics in Austria, France, Germany, Italy, Spain, and the United States
(Zalaudek et al., 2008). Out of the total number of samples, 659 received a full-body
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skin exam without a dermoscope, and 669 received a full-body skin exam with a
dermoscope (Zalaudek et al., 2008). Prior to the actual study, providers were asked to
estimate the length of time required to perform a full-body skin exam with and without
a dermoscope. They estimated it takes 6.3 minutes to perform a full-body skin exam
without a dermoscope and 10.7 minutes to perform a full-body skin exam with a
dermoscope (Zalaudek et al., 2008). Study results showed the actual time for a fullbody skin exam with and without a dermoscope was 2.4 minutes and 1.1 minutes,
respectively (Zalaudek et al., 2008). Furthermore, the length of time for a full-body
skin exam without a dermoscope did not increase with the number of lesions and a
minimal increase in the length of time for a full-body skin exam with a dermoscope
with the number of lesions (Zalaudek et al., 2008). Overall, the total duration for an
actual full-body skin exam with or without a dermoscope was less than three minutes
(Zalaudek et al., 2008).
Primary care providers do not feel confident in melanoma detection and are
overburdened with addressing other health concerns (Jiang et al., 2017). The study
talked about systematic and personal barriers to incorporating skin examinations in
daily practice. One of the most common barriers was time constraint (Jiang et al.,
2017). Other barriers included undressing a patient for the full-body skin exam,
uncertainty about the lesions, and workload constraints (Jiang et al., 2017). Despite
personal barriers, the study showed institutional barriers to implementing evidencebased intervention of melanoma screening. The barriers were lack of participant’s
enthusiasm, organization’s culture, high cost of implementation, intensive time
demands, and interaction among these factors (Jiang et al., 2017). Thus the findings
supported that a provider’s confidence and skills improvement are not enough;
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planning and preparation at the institutional level are imperative for the successful
implementation of melanoma screening.
In summary, skin cancer screening is important; however, there are barriers
and facilitators to skin cancer screening in a primary care setting. Even though time
constraint is one of the common barriers to skin cancer screening, a randomized study
showed a full-body skin exam takes 2.4 minutes and 1.1 minutes with and without a
dermoscope, respectively, which is not significant as compared to the risk associated
for melanoma (Zalaudek et al., 2008). Other barriers include lack of confidence level
among primary care providers. Even though the curriculum on skin cancer screening
showed improvement in the confidence level of the providers in detecting melanoma,
providers may not be willing to complete the curriculum in a realistic situation in a
clinic setting. The Quereux et al. (2012) study with the SAMScore utilized general
providers who were not trained in diagnosing melanoma early. Thus the study
concluded the SAMScore was a useful tool and could be used to identify patients at
high risk for melanoma, and primary care providers may need to have special training
to identify those patients. But, the training and education on melanoma and its
screening are always a good resource to providers. Thus this scholarly project used a
melanoma early detection provider toolkit as an optional resource for the providers
instead of making the toolkit mandatory for providers, which could possibly act as a
barrier to the project implementation.
Melanoma Screening Interventions
Several programs have been developed to teach primary care providers
melanoma risk factors, diagnosis, biopsy, and referral. Commonly used programs are
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a mastery learning program on melanoma, a melanoma early detection provider
toolkit, and the informed curriculum.
Mastery learning program. Robinson et al. (2018) performed a randomized
controlled trial to assess the efficacy of a mastery learning program at improving
primary care providers’ skills in visual and dermoscope inspection. The learning
program had three units: visual and dermoscopic assessment, diagnosis and
management, and deliberate practice (Robinson et al., 2018). The program was
developed by a team of dermatologists, primary care providers, and medical educators
over 11 months (Robinson et al., 2018). Of a total of 181 eligible primary care
providers, only 90 providers were randomly chosen for the study (Robinson et al.,
2018). They were divided into intervention and control groups. The control group
was given the posttest after three months without education on melanoma (Robinson
et al., 2018). The intervention group was given a personal identification number and a
link to a program to complete the educational units (Robinson et al., 2018). An
analysis of covariance was conducted to determine the efficacy of the intervention
(Robinson et al., 2018).
The primary care providers in the intervention group answered more questions
correctly on the posttest, had no false-negative identification of melanomas, and had
fewer false-positives than the control group (Robinson et al., 2018). Furthermore, the
primary care providers in the intervention group referred fewer benign lesions, greater
melanoma lesions than the control primary care providers (Robinson et al., 2018). As
a result, it may significantly reduce healthcare costs, decrease patient anxiety, and
reduce the burden of physician visits (Robinson et al., 2018). The study also
emphasized that opportunistic screening among at-risk patients improves the detection
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of early melanoma without unnecessary expenses or procedures and the time burden
for the patients (Robinson et al., 2018).
Informed curriculum (Internet curriculum for melanoma early detection).
The informed curriculum was developed as an educational course for primary care
providers with a grant from the Melanoma Research Alliance (Weinstock et al., 2018).
The goal of the curriculum was to improve the detection of skin cancer by increasing
physician knowledge and skills on melanoma (Weinstock et al., 2018). The
curriculum consists of 10 case studies on the ABCDE of melanoma, ugly duckling
signs, seborrheic keratosis, nodular melanoma, melanoma subtypes, melanoma risk
factors, basal cell carcinoma, and dermoscopy (Weinstock et al., 2018).
The Internet curriculum for the melanoma early detection group developed an
interactive and online skill-based skin cancer curriculum for primary care providers to
improve confidence and skills for skin cancer detection (Jiang et al., 2017). The
sample population consisted of 54 primary care providers from the two health
maintenance organizations of the nine integrated health systems (Jiang et al., 2017).
The training was offered as continuing medical education credits to the primary care
providers. After the training, primary care providers completed a 30-minute feedback
session on the curriculum by the focus group. Four main domains were discussed
during the session: overall impressions of the curriculum, recommendations for
improvement, current skin examination practices, and suggestions for increasing skin
screening by primary care providers (Jiang et al., 2017).
The primary care providers thought that it was beneficial to their practice. The
curriculum helped to increase their confidence level at recognizing and diagnosing
melanoma and making appropriate referrals (Jiang et al., 2017). Some primary care
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providers suggested the curriculum should be taught by experts (dermatologists) for
questions and direct feedback.
Melanoma early detection provider toolkit. The study consisted of a self-paced
online educational intervention for the providers regarding the melanoma screening
using melanoma early detection provider toolkit from the Oregon Health and Science
University (OHSU), Department of Dermatology (2001-2019). The written
permission was received from the OSHU to utilize the toolkit for the project as an
optional resource for the providers (see Appendix A). The toolkit has a total of six
sections and takes approximately three to four hours for participants to complete
(OHSU, Department of Dermatology, 2001-2019). The toolkit is online and is free to
anyone wanting to learn more about melanoma. The six sections of the toolkit include
pretest, screening and biopsies, visual identification of melanoma versus benign,
INFORMED case-based skin cancer education, resources for patient education, and
final evaluation (OHSU, Department of Dermatology, 2001-2019). The toolkit also
provides continuing medical education for the participants. During the educational
intervention, participants learn about melanoma, incidence and mortality of
melanoma, screening recommendations for high risk patients, rapid full-body skin
exams, best practices for biopsies, practice identifying melanoma or benign lesions,
and how to educate patients on early detection and self-exams (OHSU, Department of
Dermatology, 2001-2019). The OHSU, Department of Dermatology partnered with
Knight Cancer Institute and launched a public campaign called Our War on Melanoma
on May 18, 2019. The toolkit was designed with input from primary care and
specialty providers in Oregon. The vision of the toolkit was to eradicate melanoma in
Oregon by increasing early detection and treatment and prevent deaths, suffering, and
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high costs related to the late stage of melanoma (OHSU, Department of Dermatology,
2001-2019). The toolkit has the following four objectives.





Identify high-risk patients.
Apply screening recommendations.
Diagnose melanoma and non-melanoma skin cancer with increased
accuracy.
Educate patients using provided resources. (OHSU, Department of
Dermatology, 2001-2019, Learning objectives section)

Summary. Several educational trainings are available to primary care
providers to improve their skin cancer screening skills and confidence levels in
diagnosing melanoma early. The length of the educational training plays an important
role in having primary care providers complete the module. Most of the educational
trainings on melanoma are approximately two to three hours or longer, which
discourages providers from completing the training. As a result, they do not perform
melanoma screening among their patient population; therefore, it is important
educational training to be of reasonable length and have important information on
melanoma. Also, standardized training programs on melanoma are lacking for
primary care providers.
Conceptual Framework
Avedis Donabedian, a professor at the University of Michigan, School of
Public Health, was born to Armenian parents in 1919 in Beirut, Lebanon, and was
raised in Ramallah, Palestine (Ayanian & Markel, 2016). He attended medical school
and became the director of the faculty and student health service of the American
University in Beirut (Ayanian & Markel, 2016). In 1953, he received a scholarship to
study epidemiology and health services administration at the Harvard School of Public
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Health (Ayanian & Markel, 2016). In 1961, he joined the University of Michigan
(Ayanian & Markel, 2016).
In 1966, Donabedian proposed a framework using a triad of structure, process,
and outcome to evaluate healthcare quality. The structure was defined as the settings,
qualifications of providers, and administrative systems through which care takes place
(Ayanian & Markel, 2016). In other words, the structure reflects the attributes of the
service or provider such as staff to patient ratios and operating times of the service
(Achieving Community Transformation Academy, n.d.). The process was defined as
the components of care delivered and the outcome was defined as a recovery,
restoration of function, and survival (Ayanian & Markel, 2016). The process
measures reflect how the systems and processes work to deliver the desired outcome
such as patients receiving certain standards of care or staffs washing their hands
(Achieving Community Transformation Academy, n.d.). The outcome measures
reflect the impact of the process on patients and the end result of the improved process
change such as reduced mortality, reduced the length of stay, reduced hospitalacquired infections, and improved patients experience (Achieving Community
Transformation Academy, n.d.). The three proposed concepts are the foundation of
the quality assessment in today’s world. This concept has been used by the National
Quality Forum, National Committee for Quality Assurance, and Medicare to assess the
quality of healthcare (Ayanian & Markel, 2016).
A study was done to assess the quality of care for patients boarding in the
emergency department and to recognize the potential solutions to improve quality
using the Donabedian conceptual model (Liu, Singer, & Camargo, 2011). The
structure included boarding in the emergency department such as physical
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environment, providers’ skill set/practice/distraction, nurses’ skill set/distraction, and
handoffs (Liu et al., 2011). The process resulting from the structure included limited
observation of those patients, compromise in comfort from being in the holding area
with loud noise and without privacy, diagnosis delay/error, and therapy delay/error
(Liu et al., 2011). The outcome of the study included quality of care from two
perspectives: patient and hospital. The patient perspective included safety (adverse
events/errors, mortality, and morbidity), timely, patient-centered, effective, equitable,
and efficient (Liu et al., 2011). The hospital perspective included liability and
provider satisfaction (Liu et al., 2011). The study showed how the Donabedian model
illustrated the impact of certain structural problems on processes leading to poor
outcomes while providing care to boarded patients in the emergency department (Liu
et al., 2011). It concluded that the model was useful as a practical framework to assess
the quality of care of boarded patients in an emergency department so that an
evidence-based solution could be implemented (Liu et al., 2011).
Kobayashi, Takemura, and Kanda (2011) conducted a study to know if patient
experiences are related to nursing services based on Donabedian’s approach. The
study hypothesized that classifying patient experiences related to nursing service using
Donabedian’s approach would be useful in improving the quality of nursing care
(Kobayashi et al., 2011). Patient experiences were classified under the structure,
process, and outcome (Kobayashi et al., 2011). The structure consisted of the
convenience of care, comfort of surroundings, and privacy (Kobayashi et al., 2011).
The process consisted of the appropriateness of care procedures, patient–nurse
interactions, and patient participation in the care process (Kobayashi et al., 2011).
Outcomes of the study were changes in physical status, changes in patient knowledge,
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and patient satisfaction (Kobayashi et al., 2011). A total of 2,571 participants were in
this study with an approximate 78.5% response rate (Kobayashi et al., 2011). The
study concluded that the Donabedian model was successful at classifying patient
experiences related to nursing care (Kobayashi et al., 2011). As a result, this model
can be utilized by the practitioners, managers, and policymakers at identifying causes
and effects of nursing practice to improve quality (Kobayashi et al., 2011).
The Donabedian model acted as a foundation for this scholarly project (see
Figure 1). The three components of the model will be discussed to improve patient
outcomes of melanoma screening. It was used to identify patients at high risk for
melanoma in a rural underserved primary care clinic. It assisted the project lead to
assess the current structure and process of the clinic to melanoma screening and
implement the evidence-based melanoma screening workflow algorithm to the current
practice in order to improve patient outcomes.

Figure 1. Donabedian model for quality of care.
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Summary
To summarize, the recommendation for melanoma screening of risk
populations varies across national and international organizations. Currently, there is
a lack of a standardized melanoma screening recommendation, guideline, model, or
tool to identify patients who are at high risk for melanoma. Due to the lack of a
systematic approach and recommendation, melanoma is not identified and diagnosed
early, causing a delay in the treatment and an increase in mortality and morbidity
related to melanoma. Additionally, there are several identified barriers to melanoma
screening leading to a lack of consistent screening in a primary care setting. Several
tools and techniques are used to perform melanoma screening; however, barriers to
melanoma screening must be addressed or minimized in order to incorporate
melanoma screening in everyday practice in primary care settings. The Donabedian
model acted as a foundation for this scholarly project in implementing a melanoma
screening algorithm in a rural and underserved primary care clinic in Northern
Colorado.
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CHAPTER III
METHODOLOGY
Design
The Doctoral Nursing Practice (DNP) scholarly project is a quality
improvement project. The project was carried out at one of the federally qualified
health centers in a rural and small mountain community in northern Colorado. The
health center had two full-time providers and five medical assistants who participated
in the intervention to introduce the algorithm into the primary care setting. Out of the
two full-time providers, one was the medical director and the other one was a
physician assistant.
Setting
The project was implemented at one of the federally qualified health centers.
This health center is the only such organization within a 30-mile radius that provides
primary care services to publicly insured patients and to all community members,
regardless of their ability to pay. The health center is in a rural mountain resort
community with a population of approximately 7,000 permanent inhabitants, with
only three healthcare organizations and one dermatologist serving the community. In
2018 the health center had a 1,910-patient population with 890 males and 1,020
females, among which 575 patients were Hispanics, 1,239 patients were Whites, and
96 patients were unreported.
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The health center had two full-time family practice providers who participated
in the project protocol. The two full-time providers and medical assistants provided
verbal consent to participate in the project. The patients who participated in the
scholarly project filled out a written consent (see Appendix B) prior to filling out the
self-assessment of melanoma risk score (SAMScore) and participating in the project.
The clinic manager and the medical director provided written permission to conduct
the project at the clinic (see Appendix C), and the project lead obtained approval from
the clinic Institutional Review Board and from the University of Northern Colorado
Institutional Review Board (see Appendices D and E). The health center had a
volunteer dermatologist who in the past use to see patients with melanoma until
recently when he retired from the practice. Currently, no dermatologist was at the
health center. Thus non-dermatologist providers had undertaken full responsibility for
skin cancer and melanoma screening in the clinic, in addition to many other preventive
and treatment interventions, as referring patients to a dermatologist for skin screening
outside the system, which can be expensive and time-consuming. One dermatologist
was seeing patients in the community where the clinic was located, and wait times for
appointments could be three months or more.
Referrals to dermatologists outside of the community would require
approximately an hour drive each way, imposing logistical and transportation barriers
for patients. Since the health center served a low income and underserved population,
cost is a huge barrier to seeing dermatologists for most patients. Patients cannot afford
to go to or do not have access to dermatologists for melanoma screening or routine
skin checking; thus primary care providers play an important role in regular melanoma
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screening. It is vital that primary care providers assess patients for melanoma risk or
suspicious lesions during their annual exam to catch melanoma early.
The rural mountain resort community had a population of approximately 6,352
with a median age of 58.6 in 2018 and median household income of $53,025 in 2017
(U.S. Census Bureau, n.d.). The population consisted of 98.2% Whites, 7.0%
Hispanics or Latinos, and 0.8% two or more races with 6.92% of the people who
spoke a different language other than English as their primary language (DataUSA,
n.d.; U.S. Census Bureau, n.d.). Spanish was the second most common language
spoken by the people in the community with a rate of 4.72% (DataUSA, n.d.).
Approximately 12.3% of the total population in the community lived below the
poverty line (U.S. Census Bureau, n.d.). In 2014, approximately 49% of males and
52% of females were in the community (U.S. Census Bureau, n.d.).
Sample
The project had two sample populations. The first sample population included
the two full-time providers and five medical assistants at the health center who were
presented with the evidence-based algorithm and screening tool and completed the
survey questionnaires. The second sample population was the patients who qualified
for evaluation for melanoma screening and whose charts were retrospectively
reviewed as they met the criterion of presenting for an annual wellness visit during the
specified duration of the project. The targeted sample duration for the adult patients
was one month in the control group and one month in the intervention group. The
primary care clinic saw approximately four to five wellness visits with new and
established patients with approximately three to four patients who were English
speaking in between the two providers in a day (H. Fields, personal communication,
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May 13, 2019). Thus the total number of patients in the project was projected to be 60
to 80 during the intervention month.
Inclusion Criteria
The sample population for patients eligible for melanoma screening included
adult patients aged 35 to 75 years presenting for their annual physical. Also, they
were able to read and write in English in order to complete the SAMScore by selfreport because the SAMScore had only been validated in the English and French
languages. Also, the unvalidated and translated version of the tool may create
difficulty with the interpretation of the results given a small and a non-homogenous
sample size of the project.
Target Age Group for Skin
Cancer Screening
The comparison of melanoma was done with the other cancers with the U.S.
Preventive Services Task Force (2016) grading of A or B to determine the age range
for melanoma to screen. The recommendations were based on the degree of certainty
that the net benefit of screening was either substantial or moderately substantial even
though the rationale for the screening age for other cancers was unclear (Johnson et
al., 2017). Four cancers were chosen: colorectal cancer, cervical cancer, breast cancer,
and lung cancer. First, the number of affected individuals with the above-mentioned
cancers within the recommended age range was determined. Then, the screening age
range for the cancers was associated with age-stratified incidence, mortality rates,
median age at diagnosis, and total percentage of incidence rates falling within that age
range (Johnson et al., 2017). Next, the number of affected individuals in each
category for cancers was determined. The age range was very similar among the
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grade A and B cancers, and it provided a reproducible approach to define a
recommended age range for skin cancer screening (Johnson et al., 2017).
For this purpose, data from the National Cancer Institute’s Surveillance,
Epidemiology and End Results registry were used. The study showed that the
initiation of screening occurs at an age in which the slope of the incidence and
mortality curves are at or near the steepest incline, and screening ends at an age in
which the incidence and mortality curves are at or near the steepest incline (Johnson et
al., 2017). For melanoma, the steepest incline for the slope of the incidence and
mortality curve was near age 35 years and the steepest decline was near age 77 years
(Johnson et al., 2017). Furthermore, 70% of melanoma cases fell within the 35 to 74
years age range, 60% fell within the 45 to 74 years age range, and 86% fell within the
35 to 84 years age range with cases from 2008 to 2012 (Johnson et al., 2017). The
U.S. Preventive Services Task Force (2016) suggested that the median age of
diagnosis for melanoma to be 63 years which means that the range of possible
initiation of screening should be somewhere between 35 and 51 years (Johnson et al.,
2017). However, Johnson et al. (2017) suggested a slightly older termination of
screening at age 77 years for melanoma with the initiation age being 35 years old.
Johnson et al. stated that it seemed to be reasonable to have the screening age of 35 to
75 years for melanoma.
Exclusion Criteria
Patients were excluded who were younger than age 35 or older than 75 years
old; were being seen for an acute problem and not for preventive care; and did not
speak, read, and write English. Patients presenting for a Pap smear or well-woman
care as a chief complaint were also excluded because, per the providers at the clinic
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these visits usually do not provide enough time for non-female reproductive exams (H.
Fields, personal communication, May 13, 2019). Providers usually did not perform
any routine annual labs or address annual screenings such as colonoscopy during the
Pap smear or well-women care visits. Patients are usually instructed to make other
appointments for their annual physical, where annual screening labs can be discussed
at length and can be followed up on as needed.
Project Mission, Vision, Objectives
Mission
The mission of the project was to pilot an evidence-based melanoma screening
algorithm into annual visits in a primary care clinic. The project also aimed to assess
and improve provider and clinical staff knowledge of and confidence in their ability to
provide such screening as part of routine preventive care in this setting.
Vision
The vision of this project was to increase screening for melanoma in primary
care in order to improve patient outcomes downstream. It is accepted that early
detection reduces melanoma-related morbidity and mortality and primary care plays a
crucial role in this process.
Specific Objectives of the Project
Melanoma screening can be incorporated into primary care, and it decreases
the mortality and morbidity rate related to melanoma complications. The long-term
goal of this scholarly project was to identify patients at high-risk for melanoma during
adult wellness visits in a primary care setting using the evidence-based melanoma
workflow algorithm (see Appendix F) to diagnose melanoma early for timely
treatment in order to eventually decrease morbidity and mortality rates related to
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melanoma and its complications. The specific objectives for the project were as
follows:
1.

Conduct a lunch and learn session to introduce the melanoma screening
workflow algorithm to the providers and medical assistants at the clinic
in mid-August 2019.

2.

Implement a pilot of evidence-based melanoma workflow algorithm for
primary care providers and medical assistants to identify patients at
high risk for melanoma at the clinic during the months of August and
September 2019.

3.

Appraise the number of patients identified as high risk for melanoma
during the intervention month of August or September and compare it
to the control month of April at the end of September 2019.

4.

Appraise the number of patients who were positive and negative for
SAMScore and interventions for the ones with a positive SAMScore by
performing retrospective chart review in September 2019.

5.

Report an increase in the intention among providers and medical
assistants of using the evidence-based algorithm in clinical practice
compared to prior to the implementation of the algorithm.
Project Plan

An informal meeting was held with the medical director and the manager of
the primary care clinic to discuss general screening needs for the population at the
clinic. The providers at the clinic followed the screening recommendations and
guidelines from the U.S. Preventive Services Task Force (2016) for the majority of the
screening such as colorectal screening, cervical cancer screening, and breast cancer
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screening. The project lead expressed interest in melanoma screening and the
importance of melanoma screening in a primary care clinic by primary care providers.
It was mutually agreed that melanoma screening was important and could benefit the
population of the clinic. Primary care providers expressed that one of the major
barriers to melanoma screening was the time and co-morbid conditions of the patients
such as diabetes, hypertension, hyperlipidemia, and thyroid issues at the clinic.
Primary care providers were highly qualified and knowledgeable in melanoma
screening. They agreed that melanoma screening could be incorporated into the
current practice to identify patients at high risk for melanoma; however, the barriers to
melanoma screening such as time and medical complexity should be considered.
Melanoma Screening Algorithm
Development
After the initial interview with the medical director and manager, it was
determined that the first step of the project would be to develop an algorithm for the
providers and staff to easily determine changes in the workflow to incorporate the
more intentional, evidence-based melanoma screening in the clinic. Steps of the
algorithm development included an exhaustive literature review to determine the best
risk prediction models, melanoma screening tools and techniques, barriers to
melanoma screening and implementation of the risk prediction models, tools and
techniques, and melanoma screening interventions that could be utilized to integrate
melanoma screening in a primary care setting by the primary care providers. After the
review, the project lead generated a draft algorithm to be reviewed by the experts and
clinic staff/providers. The draft algorithm was reviewed by the medical director of the
clinic and three advanced practice nurse practitioners to determine the validity and
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feasibility of the algorithm and identify any potential issues with the workflow prior to
the pilot of the project. Once the validity of the algorithm was determined, the
algorithm was introduced to the staff at the clinic in August 2019 and piloted during
the months of August and September 2019.
Staff and Provider Education
A lunch and learn session was held at the clinic to inform the medical
assistants and providers about the project, algorithm, outcomes measures, and plan of
the project. The link to the melanoma early detection toolkit for the providers (Oregon
Health and Science University [OHSU], Department of Dermatology, 2001-2019) was
provided to the providers as an optional available resource to melanoma screening and
was an open-access resource. However, providers at the clinic were fully licensed and
were presumed to be proficient at melanoma screening, so evaluation of the
participation in the education intervention and clinical knowledge of the providers was
not evaluated in this scholarly project.
The scholarly project utilized the SAMScore for melanoma screening as an
initial screening tool that was filled out by the patients while they were waiting for the
providers in the exam room. Dr. Brigitte Dreno was contacted via e-mail at the skin
cancer unit at Nantes University Hospital in France, and written consent was given to
utilize the tool for the project (see Appendix F). The lunch and learn session was held
for the providers and medical assistants approximately one week prior to the
implementation of the project. The duration of the lunch and learn session was
approximately 20 minutes with an additional 10 minutes for questions regarding the
project. The lunch and learn session included information on melanoma, mortality
and morbidity rate of melanoma, benefits of melanoma screening on high-risk
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individuals, melanoma screening algorithm, and role of medical assistants on giving
the SAMScore to high-risk patients with annual visits.
The following objectives were developed by the project lead for the lunch and
learn session at the rural and underserved federally qualified health center:
1.

Providers would be able to identify the three criteria needed for the
SAMScore to be positive by the end of the lunch and learn session.

2.

Providers would be able to recognize the international classification of
diseases (ICD) 10 diagnosis code for melanoma screening by the end of
the lunch and learn session.

3.

Providers would be able to list the keywords for the plan section of the
subjective, objective, assessment, and plan note for a positive
SAMScore by the end of the lunch and learn session.

4.

Providers would have an increase in the intention of utilizing the
evidence-based algorithm by the end of the lunch and learn session.

5.

Medical assistants would be able to outline the inclusion and exclusion
criteria for the participants of the study by the end of the lunch and
learn session.

6.

Medical assistants would be able to summarize the steps on what to do
with the SAMScore after the provider had reviewed it by the end of the
lunch and learn session.

Pilot Algorithm Implementation
One week from the lunch and learn session the algorithm, together with the
SAMScore, was implemented during the annual visits of all patients between the age
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range of 35 to 75 years old and were English speakers only, as there was not a
validated Spanish-language version of the SAMScore tool available.
Since the SAMScore saves time and, therefore, reduces barriers for clinic staff
to identifying patients at risk for melanoma by using self-report questionnaires,
patients who had a limited ability to read and write were excluded from the postintervention group as the evidence-based algorithm requires patients to read and
complete the SAMScore questionnaire independently before being treated by the
provider. The two providers were given a no signature consent form (see Appendix
G). The medical assistants completed the individual investigator agreement form to be
covered under the Institutional Review Board (see Appendix H). The medical
assistants identified annual wellness visits that met the inclusion criteria for the
project. After patients were checked in by the front desk staff and were roomed by the
medical assistants, patients were asked if they were willing to participate in the project
by the medical assistants. Patients who agreed to participate in the project signed the
consent form (see Appendix B) prior to filling out the SAMScore (see Appendix I).
The medical assistants then gave the SAMScore to the consented patients to fill out
while they were waiting to be seen by the providers in the exam room. The medical
assistants instructed patients not to put any patient identifiers such as name, age,
gender, or ethnicity in the SAMScore for privacy purposes. The SAMscore was
completed by the patients while they were waiting to be seen by the providers in the
exam room. Based on the decision tree algorithm, the providers then identified
patients at risk for skin cancer and decided if a targeted or full-body skin exam was
warranted. If the patient met the criteria for risk for melanoma skin cancer based on
their SAMScore or if the patient had concerns about a lesion meeting the ugly
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duckling or asymmetry, border irregularity, color that is not uniform, diameter greater
than 6 mm, and evolving size, shape or color (ABCDE) criteria, providers were
instructed to document a diagnosis code for screening for melanoma or encounter for
screening of malignant neoplasm of skin as ICD 10 code Z 12.83 in the patient chart.
Next, providers documented any intervention plan related to the skin cancer or
melanoma screening diagnosis, including but not limited to the keywords annual skin
cancer exam or biopsy or referral to dermatology or primary prevention. The
completed SAMScore was collected by the medical assistants and copies of the
SAMScore were made. The original completed SAMScore was filed separately in a
secure folder behind the nurse’s desk for the project lead to collect. The copied
SAMScore was scanned into the patient’s electronic health records. The project lead
accessed the charts of the patients who met the inclusion criteria but only reviewed the
charts of patients who had consented to participate in the project and had filled out the
SAMScore. The connection between the patients who completed the SAMScore and
their electronic health record was not made since the completed SAMScore did not get
scanned into the electronic health record.
The consent forms were stored separately in a confidential folder in a secure
area behind the nurse’s desk. The agreement forms and consent forms were collected
and transmitted to the University of Northern Colorado and will be stored at the
School of Nursing in the Scholarly Project Advisor’s office in a locked space for three
years before they are destroyed.
The SAMScore was printed in a bright-colored yellow paper with an ordered
number (no patient identification was used) written on the top of the sheet so the
project lead could keep track of all the screening tools filled out by the patients. The
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patients would fill out the SAMScore and have it reviewed by the providers. After the
SAMScore was reviewed by the providers, the bright yellow SAMScore paper was
then copied without the patient’s identifiers by the medical assistants for the project
lead to collect at the end of the project. The copy was scanned into the electronic
health record. The original bright yellow color paper with the SAMScore was set
aside by the medical assistants in a confidential folder in a secure area at the back of
the nurse’s desk for the project lead to collect. All the collected data on the
SAMScore were confidential. No patient identifiers were included.
Retrospective Chart Review
The project lead performed a retrospective chart review of the patients for the
control month of April 2019. According to the medical director and manager of the
clinic (H. Fields and M. Dungan, personal communication, July 3, 2019), the
electronic health system at the clinic did not have the ability to pull data on melanoma
or skin cancer screening without patient identifiers. Also, the primary complaint of
the visit varied depending on the subjective and objective information during the
appointment, and the providers end up doing annual screening labs and preventive
screenings even though the primary complaint was not an annual wellness visit (H.
Fields and M. Dungan, personal communication, July 3, 2019). Thus the medical
director and the manager at the clinic recommended that the project lead review each
patient chart between ages 35 to 75 years seen by the two providers during the month
of April 2019 irrespective of the type of the visit to obtain accurate data on the number
of melanoma screening. The project lead utilized a binomial method (yes/no) while
reviewing the charts of the patients for melanoma or skin cancer screening (see
Appendix J). During the implementation of the project, it was identified that further
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data were necessary to make the project stronger and robust; thus an addendum to the
Institutional Review Board of the University of Northern Colorado was submitted and
approved on September 12, 2019 (see Appendix K). After the approval from the
Institutional Review Board, the total number of annual wellness and established care
visits were collected for the control month of April 2019.
Intervention Chart Review
The chart review was done for the patients who consented (see Appendix B) to the
project during the intervention month by the project lead. The scanned SAMScore in
the chart of the patients was reviewed and matched with the original SAMScore as
identified by the numbers on the top of the scanned SAMScore. Then, the chart was
reviewed for diagnosis in the assessment section and keywords in the plan section of
the subjective, objective, assessment, and plan note. The project lead identified the
number of patients with a positive and negative SAMScore. The project lead also
compared the number of melanoma screenings to identify at-risk patients during the
intervention month (August/September 2019) to the control month (April 2019). The
intervention chart review (see Appendix L) collected data on age, gender, number of
patients positive for SAMScore, number of patients negative for SAMScore, number
of patients with a melanoma screening ICD 10 code, number of patients with
keywords in the plan note section, and number of patients who received intervention
or education. The addendum to the Institutional Review Board of the University of
Northern Colorado was submitted and approved on September 12, 2019. As a result,
the total number of annual wellness visits, establish care visits, and the number of the
patients eligible and not eligible to participate in the study were also collected for the
intervention months of August/September 2019.
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The data collected from the retrospective and intervention chart review were stored
in an encrypted file with a password, and the project lead was the only holder of the
password. Those data were destroyed at the end of the implementation of the project.
Education Evaluation
The survey questionnaires were administered to the providers and medical
assistants before and after the lunch and learn session. The two providers and the five
medical assistants were given a no signature consent form. The providers and medical
assistants were asked to provide survey identification that included a numerical format
of their birthday month and date. The pre-survey questionnaire for the providers (see
Appendix M) assessed the providers’ intention of screening patients for melanoma or
utilizing toolkits to help them in assessing and diagnosing melanoma and if they had
heard or learned about SAMScore. The post-survey questionnaire for the providers
(see Appendix N) assessed their intention to use the algorithm and toolkit,
understanding of the SAMScore, risk factors to be considered at high risk for
melanoma, ICD 10 code, and keywords for the plan section of the subjective,
objective, assessment, and plan note. It also had a space to give comments and
feedback on barriers to screening, the algorithm, and/or their experiences with skin
cancer screening during preventive primary care. The post-post-survey questionnaire
for providers (see Appendix O) was used at the end of the implementation of the
project to assess if the staff at the clinic intended to utilize the algorithm for melanoma
screening for the annual wellness visits in the following months. The post-post-survey
questions for the providers assessed their intention of utilizing the algorithm to screen
for melanoma in the future and open-ended questions on their feedback to the project.
The pre-survey questionnaire for the medical assistants (see Appendix P) assessed if
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they had learned or heard about the SAMScore and specific questions about the
SAMScore. The post-survey questionnaire for the medical assistants (see Appendix
Q) assessed their knowledge of the inclusion and the exclusion criteria for the
participants of the project and their role with the completed SAMScore. It also had a
space to provide written comments to the open-ended questions. The survey
questionnaire was confidential and anonymous. The survey questionnaire was stored
in a confidential folder inside the office of the medical director of the clinic and was
destroyed at the end of the project implementation. The medical director of the clinic
and the project lead were the only two people with access to those survey
questionnaires.
It was expected that the staff and providers would be able to choose the correct
answers in the post-survey questionnaire after the lunch and learn session. Feedback
was used to evaluate the lunch and learn session and make changes to the
implementation plan or algorithm as needed prior to the implementation of the
algorithm in August/September 2019. The feedback obtained in the post-post-survey
question was utilized to provide the direction to improve melanoma screening in the
future. Table 1 shows a summary of this project using the Donabedian framework.
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Table 1
Summary of Project
Time

Current

Structure

2 family practice providers & 5
medical assistants
FQHC

Process

No protocol to screen patients with melanoma
Melanoma screening at provider’s discretion
depending on subjective and objective
information.

Rural and underserved patient
population

Outcomes (patient focused)

Currently, average number
of patients screened for
melanoma is approximately
3 per month between two
full time providers (H.
Fields, personal
communication, May 21,
2019)

No formal training or education
on melanoma screening
Historically, there was a
dermatologist who volunteered,
but now he has retired, and PCP
are responsible for all
screening.
There are 1-2 dermatologists in
the community with wait list at
least 2-3 months.
Proposed
changes

Lunch and learn session
regarding melanoma screening
workflow algorithm for 2 full
time providers and 5 medical
assistants.
Make changes to the
implementation plan and
algorithm from the feedbacks
prior to implementation of the
scholarly project in August/
September 2019

Development of melanoma screening protocol
from exhaustive literature and expert review.
Medical assistants will identify patients to give
the bright yellow sheet of paper with
SAMScore who meet above mentioned
inclusion and exclusion criteria.

Increase in the number of
melanoma screening at high
risk patients age 35-75
years old compared to
control month through
retrospective chart review.

Medical assistants will ask patients and have
patients sign the consent form prior to having
them fill the SAMScore

Increase in the number of
referrals to dermatology or
biopsy or education on
ongoing care.

Medical assistants will instruct patients to
complete the SAMScore while waiting to be
seen by the providers and not to write any
patient identifiers such as name, age, gender,
and ethnicity on the sheet.

Increase in the intention
and attitude of providers
and medical assistants to
utilize algorithm at the
clinic in the future.

Providers will review the sheet and determine
if the patients are at risk for melanoma based
on positive SAMScore and/or meeting at least
one of the 3 criteria
After patients fill out the SAMScore, sheet will
be copied and put aside in an envelope for the
project lead; copied sheet will then be scanned
into patient’s medical record.
For positive SAMScore, providers will
document a relevant ICD 10 diagnosis Z12.83
as screening for melanoma or encounter for
screening of malignant neoplasm of skin and
keywords in the plan section of the SOAP note:
annual skin cancer exam or biopsy or referral to
dermatology or primary prevention.
For negative SAMScore, providers will counsel
patients on sunscreen and exposure and provide
handout from the American Academy of
Dermatology.
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Table 1 (continued)
Time

Structure

Proposed
outcomes
(evaluation
of changes)

The survey questionnaires for
providers and medical
assistants will demonstrate an
increase in knowledge
regarding the use of the
evidence-based melanoma
algorithm and its
implementation after the
“lunch and learn” session.

Process

Outcomes (patient
focused)

Melanoma screening algorithm will be
incorporated into the care of patients during
their well visits as determined by chart review
of consented patients.

90% of consented patients
who meet the inclusion and
exclusion criteria will
complete SAMScore.

Providers will provide diagnosis code and plan
in the SOAP note for those patients who have
positive SAMScore and will be screened for
melanoma as evidenced in the chart review of
consented patients.

75% of consented patients
who score positive on the
SAMScore will have ICD
10 code and keywords
listed in the plan section of
the electronic health
records.
75% of consented patients
who score negative on the
SAMScore will have
evidence of patient
education provided in their
electronic health record.

Note. FQHC = federally qualified health center; ICD = international classification of
diseases; PCP = primary care physician; SAMScore = self-assessment of melanoma
risk score; SOAP = subjective, objective, assessment, plan.

Instrumentation
The project used two instruments: the SAMScore and survey questionnaires.
Self-Assessment of Melanoma
Risk Score
The SAMScore has seven question based on the risk factors for melanoma:
skin type, freckles, history of severe blistering sunburn as a child or adolescent, living
in a country with intense sun exposure, personal history of melanoma, and first degree
relative with melanoma (Quereux et al., 2012). The patient is considered positive for a
SAMScore if any one of three criteria is met. The first criteria is presence of at least
three risk factors out of the seven risk factors, the second criteria is patients younger
than 60 years old with more than 20 melanocytic nevi on both arms, and the third
criteria is patients older than 60 years old with freckling tendency (Quereux et al.,
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2012). The SAMScore is the tool that was filled out by patients who met the inclusion
criteria. It was printed on bright yellow paper with ordered numbers written on the top
of the paper to avoid misplacement of the completed SAMScore (no patient
identification was used). The tool had instructions for the patients not to put any
patient identifiers on the sheet such as name, date of birth, or gender. After the
SAMScore was completed by the patient, the provider reviewed the tool and evaluated
if the patient had any one of the three criteria. If the patient had any one of the three
criteria, it alerted the provider that the patient was at high risk for melanoma, and thus
a skin exam was warranted. If the patient did not have any one of the three criteria,
then the providers educated the patients on the primary interventions for melanoma
and gave them the handout from the American Association of Dermatology (see
Appendices R and S). The completed SAMScore was then copied. The copied
SAMScore was scanned into the electronic health record, and the original SAMScore
was set aside in a confidential folder behind the nurse’s desk for the project lead to
collect.
Survey Questionnaire
The survey questionnaires (see Appendices M, N, O, P, and Q) were developed
by the project lead to assess the current practice for melanoma screening at the rural
and underserved primary care clinic and staff knowledge on the melanoma screening
workflow algorithm for providers and medical assistants (see Appendices T and U).
The questionnaires were given to the providers and medical assistants before and after
the lunch and learn session. The questionnaires were de-identified with a numerical
format of their birthday month and date. The pre-survey questionnaire for the
providers (see Appendix M) had a total of nine questions with one open-ended

68

question. Out of nine questions, five questions were scored as binomial with four
yes/no questions, one true/false question, and three questions were multiple-choice
with two open-ended questions. For the pre-survey, question 5 was scored as correct
if they answered three as the number of risk factors. Question 6 was scored as correct
if they answered three choices “at least 3 of the 7 risk factors, younger than 60 with
more than 20 nevi on both arms and older than 60 with freckling tendency.” For
question 7, the question was scored as correct if they answered “yes” and incorrect if
they answered “no.” The post-survey questionnaire for the providers (see Appendix
N) had a total of five questions with two yes/no questions, one true/false question, two
multiple-choice questions, and one open-ended question. For the post-survey,
question 2 was scored as correct if they answered three as the number of risk factors.
Question 3 was scored as correct if they answered three choices “at least 3 of the 7 risk
factors, younger than 60 with more than 20 nevi on both arms and older than 60 with
freckling tendency.” Question 4 was scored as correct if they answered “yes” and
incorrect if they answered “no.” The post-post-survey questionnaire for the providers
(see Appendix O) had a total of two yes/no questions and one open-ended question.
The pre-survey questionnaire for the medical assistants (see Appendix P) had a total of
six questions with two yes/no question, two multiple-choice questions, and two openended questions. The post-survey questionnaire for the medical assistants (see
Appendix Q) had a total of four questions with one true/false, two multiple-choice
questions, and one open-ended question. For the true/false question, the question was
scored as correct if they answered “yes” and incorrect if they answered “no.” For the
multiple-choice questions, the inclusion criteria for the patients to have a SAMScore
was scored as correct if they answered three choices “patients aged 35-75 presenting
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for their annual physical, able to read, write and speak English, English and Spanish
speakers.” The exclusion criteria for the patients to not have a SAMscore were scored
as correct if they answered two choices, “patients younger than 35 and older 75 for
acute visits and well women visits.”
Analysis
For the retrospective chart review, descriptive statistics, including frequency
and percentage, were used to describe the total number of annual visits and total
number of melanoma screenings over the control month. For the intervention chart
review, descriptive statistics, including frequencies and percentages, were used to
describe the total number of annual wellness visits, total number of establish care
visits, total number of consented patients, total number of completed SAMScores by
the consented patients, total number of patients positive and negative SAMScores,
total number of patients with melanoma screening as evidenced by the ICD 10 code
and keywords in the plan section, and total number of patients receiving interventions
after melanoma screening.
Analysis of the pre-, post-, and post-post-survey questionnaire was completed
using the descriptive statistics with percentages and frequencies.
Duration of the Project
An extensive literature review was performed during the months of February
and March to develop a draft evidence-based algorithm for melanoma screening with
an annual physical by primary care providers in a primary care setting. The algorithm
was validated to use for the ease of use, clarity, and accuracy by one medical doctor
and three advanced nurse practitioners prior to the implementation of the scholarly
project. Then implementation of this project began with the lunch and learn session
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with survey questionnaires to the providers and medical assistants during the month of
August 2019. The clinic team was asked to utilize the algorithm and SAMScore
questionnaires starting August 7 until September 6, 2019, for a period of one month.
The project lead retrospectively reviewed the charts of patient visits meeting inclusion
criteria that occurred during the control or comparison month (April) and the
intervention month (August 7 until September 6) and anticipated the completion of the
chart review by September 2019. The number of melanoma screenings over the
month of August 7 and September 6 were compared to the number of melanoma
screenings over the month of April.
Ethical Considerations
The scholarly project is a quality improvement project. The goal of the
scholarly project was to increase the number of patients identified as high-risk for
melanoma in the population of the primary care clinic using the project lead’s
evidence-based melanoma screening workflow algorithm. Even though the project
involved the SAMScore tool that was completed by the patients, it was de-identified
for privacy purposes for the project lead to collect. The pre-, post-, and post-postsurvey questionnaire from the providers and staff at the clinic were confidential and
de-identified as well. The risks for the participants of the project were minimal. Risks
included potential patient embarrassment to undress or lift clothing for providers to
assess the skin for melanoma or skin cancer. The project would benefit the clinic and
the patient population as this project specifically evaluated an intervention that would
improve access to evidence-based skin cancer screening in the setting in which the
project was being performed. This project was submitted for review and approval
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through the institutional review boards of the primary care clinic and the University of
Northern Colorado to evaluate any risks to the participants.
Project Limitations
One of the biggest limitations of the scholarly project was language. The
SAMScore is a self-reported tool and only available in the English and French
languages, not available in the Spanish language, and was not validated in the Spanish
language; thus the tool could only be administered to those able to read, write, and
speak English. Also, the clinic was a very small rural clinic with only two full time
providers and five medical assistants. Thus the number of staff and providers was
another limitation of the scholarly project. Further study is needed to see if the
SAMScore can be translated and validated in different languages and implemented in
a bigger clinic with a greater number of providers
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CHAPTER IV
DATA ANALYSIS AND RESULTS
The overarching aim of the Doctor of Nursing Practice (DNP) scholarly project
was to identify patients at high-risk for melanoma during the adult wellness visits in
primary care by primary care providers using the evidence based self-assessment of
melanoma risk score (SAMScore) and melanoma workflow algorithm in order to
decrease mortality and morbidity rate related to melanoma and its complications. The
DNP scholarly project was submitted and approved by the institutional review boards
of the University of Northern Colorado and the project clinic site on the first week of
August 2019. The project implementation was started on August 7, 2019, and ended
on September 6, 2019.
Survey Questionnaires
The lunch and learn session was held in the conference room at the clinic. The
two sessions were held separately for the five medical assistants and the two
providers. The pre-survey questionnaires were given to the five medical assistants and
the two providers prior to the presentation. The medical assistants and providers were
instructed to write the numerical format of their birth month and day on the pre-survey
questionnaires and post-survey questionnaires. All the medical assistants and
providers found the presentation informative and stated that they were excited to start
the project and see the result of the project. It was mutually agreed between the two
providers and the five medical assistants that the project would be implemented on the
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same day after the lunch and learn session. After the completion of the lunch and
learn session, two separate folders were made for the completed consent forms and
SAMScore and stored in a secure area behind the nurse’s desk. Any questions
regarding the inclusion and exclusion criteria of the project were answered.
Pre-Survey Questionnaires
For Medical Assistants.
Out of the five medical assistants, only one medical assistant had heard about
SAMScore because he/she had worked with a dermatologist in the past at the same
clinic who had recently retired. There were two other medical assistants who stated
that they had heard or learned about the SAMScore, but they wrote in parenthesis as
“during the presentation” (see Table 2). Four medical assistants correctly answered
the inclusion criteria for the patients to receive the SAMScore, which were patients
between 35 to 75 years old presenting for their annual physical and able to read, write,
and speak English. Three medical assistants did not answer the exclusion criteria of
the scholarly project incorrectly. One medical assistant did not answer the exclusion
criteria. All five medical assistants correctly answered their role with the completed
SAMScore filled by the patients (see Table 3). None of them had any feedback or
suggestions for melanoma screening in primary care in the pre-survey questionnaires.
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Table 2
Pre-Survey Questionnaires for Medical Assistants (Yes/No)

Item

Heard or learned about self-assessment of melanoma
risk score (SAMScore) for melanoma screening

Yes
no. %

No
no. %

3

2

60

40

Table 3
Pre-Survey Questionnaires for Medical Assistants (Correct/Incorrect)

Item

Correct
no. %

Incorrect
no. %

Inclusion criteria for the patients to have the selfassessment of melanoma risk score (SAMScore)

4

80

1

20

Exclusion criteria for the patients to have the
SAMScore

1

20

3

60

Identified the role of medical assistants with the
completed SAMSore by the patients and placing the
copied SAMcore to be scanned into the electronic
health record and original SAMScore in a secure folder
to the project lead to collect

5 100

0

Post-Survey Questionnaires
For Medical Assistants
After the lunch and learn sessions, all five medical assistants were able to
correctly answer the inclusion criteria for the patients to have the SAMScore and their
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role in making a copy of the completed SAMScore so that the copied SAMScore can
be scanned into the medical records and original SAMScore can be set aside for the
project lead to collect. Only three medical assistants correctly answered the exclusion
criteria for the patients not to have the SAMScore (see Table 4). Those medical
assistants who did not answer the exclusion criteria correctly were re-educated on the
inclusion and exclusion criteria prior to the implementation of the project. Also, a note
with the inclusion and exclusion criteria was taped at the nurse’s desk. None of the
medical assistants had any feedback or suggestions for melanoma screening in primary
care.

Table 4
Post-Survey Questionnaires for Medical Assistants (Correct/Incorrect)

Item

Correct
no. %

Incorrect
no. %

Inclusion criteria for the patients to have the selfassessment of melanoma risk score (SAMScore)

5

100

0

Exclusion criteria for the patients to have the
SAMScore

3

60

2

Identified the role of medical assistants with the
completed SAMSore by the patients and placing the
copied SAMcore to be scanned into the electronic
health record and original SAMScore in a secure
folder to the project lead to collect

5

100

0

40
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Pre-Survey Questionnaires
for Providers.
Both providers answered that they did not routinely screen patients for
melanoma and did not have a systematic method to screen patients for melanoma
regardless of the visit types.
On average, the percentage of the people screened for melanoma at the clinic
was about 25% according to both providers. Both providers had not heard or learned
about melanoma prior to the presentation. One provider did not answer the question
specific to the SAMScore for the number of risk factors to make a positive SAMScore.
The other provider answered both questions incorrectly. Both providers were aware
that the international classification of diseases (ICD) 10 code and keywords would be
used by the project lead to evaluate the objectives of the scholarly project. One
provider had heard about the melanoma screening toolkit for providers and another
provider had not heard or learned about any toolkit for melanoma screening (see Table
5). Both providers intended to use the melanoma early detection toolkit as a resource
for melanoma screening that was provided by the project lead.
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Table 5
Pre-Survey Questionnaires for Providers (Yes/No)

Item

Yes
no. %

No
no. %

Do you currently screen patients for melanoma during
their annual wellness visits?

0

2

100

Heard or learned about self-assessment of melanoma
risk score (SAMScore) for melanoma screening?

0

2

100

Heard or Learned about melanoma early detection
provider toolkit through Oregon Health and Science
University (OSHU) or any toolkit for melanoma
screening?

1

50

1

50

Intend to use melanoma early detection provider
toolkit as a resource for melanoma screening?

2

100

0

Both providers provided comments to the open-ended question in the presurvey questionnaire. One provider commented that time was the biggest barrier in
performing melanoma screening and a 20-minute appointment time was not adequate;
thus a second visit was needed for melanoma screening. Another provider commented
that time, multiple competing health conditions, and lack of a standardized practice
recommendation on melanoma screening are some of the barriers to melanoma
screening (see Tables 6 and 7).
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Table 6
Pre-Survey Questionnaires for Providers (Percentage)

Item

100%

75%

50%

25%
no. %

0%

Percentage that approximates the
number of patients currently screened
from melanoma

0

0

0

2 100

0

Table 7
Pre-Survey Questionnaires for Providers (Correct/Incorrect)

Item

Correct
no. %

Incorrect
no. %

Number of risk factors on the self-assessment of melanoma
risk score (SAMScore) to the patients to be considered at
risk for melanoma

1

50

1 50

Criteria for positive SAMScore

1

50

1 50

International classification of diseases ICD10 code and
keywords will be used to evaluate the objectives

2 100

0

Post-Survey Questionnaires
for Providers
Both providers intended to utilize the SAMScore and evidence-based
algorithm in their practice to increase the number of melanoma screening among
annual wellness visits after the lunch and learn session. Out of the two providers, one
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provider was able to correctly identify the number of the risk factor for positive
SAMScore. The same provider was able to recognize the ICD 10 code and keywords
to evaluate the objectives of the scholarly project. Also, both providers were willing
to utilize the melanoma early detection provider toolkit as a resource for melanoma
screening. Both providers provided comments to the open-ended question in the postsurvey questionnaire. One provider commented that time constraints of the
appointment as a barrier to melanoma screening in primary care. The other provider
stated, “This seems like it will be helpful—look forward to piloting this” (see Tables 8
and 9).

Table 8
Post-Survey Questionnaires for Providers (Yes/No)

Item

Yes
no. %

No

Intend to change your current practice for melanoma or skin
cancer screening by incorporating self-assessment of
melanoma risk score (SAMScore) or evidence-based
melanoma algorithm?

2

100

0

Intend to use melanoma early detection provider toolkit as a
resource for melanoma screening?

2

100

0
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Table 9
Post-Survey Questionnaires for Providers (Correct/Incorrect)

Item

Correct
no. %

Incorrect
no. %

Number of risk factors on the self-assessment of
melanoma risk score (SAMScore) to the patients to be
considered at risk for melanoma

1

50

1

50

Criteria for positive SAMScore

1

50

1

50

International classification of diseases (ICD) 10 code and
keywords will be used to evaluate the objectives

2 100

0

Post-Post-Survey Questionnaires
for Providers
The post-post-survey was given a week after the last day of implementation.
Both providers replied that they intend to continue to screen patients for melanoma
during the annual wellness visits and use the melanoma screening algorithm or
melanoma early detection provider toolkit as a resource for melanoma screening in the
future (see Table 10).
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Table 10
Post-Post-Survey Questionnaires for Providers

Item

Yes
no. %

No

Intend to continue to screen patients for melanoma or skin
cancer during the annual wellness visits

2 100

0

Intend to use the melanoma screening algorithm or
melanoma early detection provider toolkit as a resource for
melanoma screening

2 100

0

One of the providers said that the questionnaires in the SAMScore expedited
the history taking to identify patients at risk for melanoma reducing the time to ask
those questions, which was identified as one of the barriers to the melanoma screening
at the clinic in the past. The provider added that “the SAMScore was a great
conversation starter even for non-melanoma skin cancer.” Furthermore, patients who
consented to the study and filled out the SAMScore really liked the format, the
SAMScore, and the primary prevention handout from the American Academy of
Dermatology. The provider stated that the SAMScore was a great tool, and it would
be great to have it validated in the Spanish language in the future. The provider
reported, “I would like to continue the study for a longer time and would love to repeat
the study in an electronic medical record with data analytics capability [EPIC] for the
ease of the study.”
The other provider felt that the duration of the study was short, and the
exclusion criteria of the study were too restrictive since the clinic had several non-
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English speaking patients. The provider commented that the project lead did a great
job involving the staff of the clinic. The provider added that the study was well
designed and increased awareness among the patients and providers on skin cancers.
As a result, the provider screened and performed two biopsies during the intervention
month among the patients who did not meet the criteria for the study but needed the
screenings.
Implementation of the Project
Implementation of the quality improvement project started on the day of the
lunch and learn session upon agreement between the project lead, the two providers,
and the five medical assistants. Two separate folders were made by the project lead to
collect completed consent forms and SAMScore. The folders were placed in a secure
place behind the nurse’s desk. A week after the implementation of the project, an email was sent to the two providers with a link to the melanoma early detection
provider toolkit as a resource for melanoma screening. It was decided that additional
data on the number of annual visits and establish care visits for the control month of
April 2019 would make the scholarly project robust. Also, additional data on the
number of annual visits, establish care visits, and the percentage of patients who
participated in the study and did not participate in the study for the intervention month
of August/September 2019 would be important. Thus an addendum to the data
collection process was submitted and approved by the Institutional Review Board of
the University of Northern Colorado on September 12, 2019.
Throughout the implementation of the project, the medical director and the
project lead were in contact via telephone updating the project lead on the
implementation process and the number of screened patients. The medical director
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and the staff of the clinic continued to give feedback on the project. There were a total
of 10 patients who met the inclusion criteria for the project and only nine completed a
SAMScore. Out of nine completed a SAMScore, one was completed outside the
implementation month; thus it was not included in the result of the project. Also, one
patient did not consent to participate in the study but completed the SAMScore.
Retrospective Chart Review
The retrospective chart review for the control month of April 2019 was
performed after the implementation of the project (see Table 11). There were a total
of 279 patients who were seen at the clinic during the month of April 2019 between
the two providers. Among the total number of patients, there were nine annual well
visits and 18 establish care visits during the control month of April 2019 between the
two providers. Among the nine annual wellness visits, there was one well-woman
visit and two well-child checkups. Among the 18 establish care visits, there was one
well-woman visit, one well-child checkup, and four acute problem visits. There were
only two patients who were screened for melanoma or skin cancer during the visit
because both had skin concerns and had a skin check as their chief complaint of the
visit. Three patients had a history of melanoma, but it was not the primary diagnosis
or chief complaint during the visit of April 2019.
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Table 11
Retrospective Chart Review of April 2019

Total patients
no.

Annual visits
no.

Establish care visits
no.

Melanoma screenings
no.

279

9

18

2

Intervention Chart Review
The intervention chart review was started during the middle of the
implementation month September 2019. There were a total of 404 patients who were
seen at the clinic in between the two providers (see Table 12). Among those patients,
there were 40 annual wellness visits and 29 establish care visits. Among the 40 annual
wellness visits, there were 18 sports physicals, nine well-child checkups, and two
well-women visits. Among the 29 establish care visits, there were four visits that
turned into acute problem visits, one well-child checkup, and one well-woman visit.
There were 10 patients who were at the clinic for annual or establish care visits,
between ages 35 to 75 years, and able to read, write, and speak in English, making
them eligible to participate in the scholarly project. Out of 10 patients, only eight
patients consented to participate in the study and completed the SAMScore. There
was one extra consent form from a patient to participate in the study; however, it was
done on September 11, 2019, which was outside the intervention period. The
SAMScore was negative for melanoma risk for that patient. That consent form and
the SAMScore were not included in the result. Also, there was one extra SAMScore
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without a consent form, which showed that the patient who filled out the SAMScore
was negative for melanoma risk. Among the total of annual and establish care visits,
there were about 59 patients who were not eligible to participate in the study. Some of
the reasons included younger than 35 years and older than 75 years, well-women
visits, complex medical conditions, acute visits, and not able to speak, read, and write
in English.

Table 12
Intervention Chart Review of August/September 2019

Total no. of
patients

No. of annual
visits

No. of
establish care
visits

No. of patients
meeting
inclusion criteria

Number of
patients not
meeting criteria

404

40

29

10

59

There were a total of eight patients who consented to participate in the study
and completed the SAMScore. The age range for the completed SAMScores included
patients 38 years to 70 years out of which there were five females and three males.
Three patients were positive for SAMScores, and five patients were negative for
SAMScores. Among the positive SAMScores, there were two females and one male.
All the patients who were positive for SAMScores had ICD 10 diagnosis code as
Z12.83, keywords (annual skin cancer exam or biopsy or referral to dermatology or
primary prevention) and interventions (counseling and providing handout from the
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American Academy of Dermatology) in the chart. However, none of the patients who
were positive for SAMScore had any suspicious lesions or skin issues during the total
skin exam that needed skin biopsies. For five patients who were negative for
SAMScores, two patients had ICD 10 diagnosis code as Z12.83, keywords, and
interventions charted; two patients did not have ICD 10 diagnosis code, keywords, and
interventions charted; and one patient had ICD 10 diagnosis code, but no keywords
and interventions charted.
Conclusion
The DNP scholarly project was implemented to increase melanoma screening
and identify patients at high risk for melanoma in a small rural clinic in northern
Colorado. The project utilized the SAMScore and melanoma screening algorithm.
Prior to the implementation of the project, the clinic did not have a protocol to screen
patients for melanoma, and it was up to a provider’s discretion to screen patients for
melanoma depending on subjective and objective information. With the
implementation of the project, the melanoma screening increased from two patients
during the control month to eight patients during the intervention month, with a 300%
increase in melanoma screening. Furthermore, it increased patients’ and providers’
awareness of melanoma and the importance of diagnosing melanoma early to prevent
long term complications of the disease.
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CHAPTER V
DISCUSSION
Melanoma is a fatal skin cancer and is on the rise. There is a lack of a
standardized tool and inconsistent guidelines and recommendations on melanoma
screening for primary care providers. Furthermore, there are an inadequate number of
dermatologists in the United States to screen and treat people with suspected or
diagnosed lesions or skin issues. The majority of doctor visits are in a primary care
setting; thus primary care providers are at an ultimate position to screen and treat
patients with suspicious lesions, to identify if they are at high-risk for melanoma, and
to educate patients on prevention of melanoma or nonmelanoma skin cancers. This led
the project lead to develop an evidence-based algorithm using the self-assessment of
melanoma risk score (SAMScore) to increase melanoma screening at a federally
qualified health center. The SAMScore served as a primary risk prediction model for
the algorithm which was already validated in the English and French languages to
identify patients at risk for melanoma. The primary stakeholders of the project
included five medical assistants, two providers, and consented patients.
Project Objectives
The overall aim of this project was to improve melanoma screening at a
federally qualified health center. The data from the retrospective and intervention
chart review demonstrated the meeting of this objective. A review of all patient
records during the control month of April 2019 resulted in a total of two melanoma
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screenings. With the implementation of this Doctor of Nursing Practice (DNP)
scholarly project, there was an increase in the number of melanoma screenings from
two to eight, a 300% increase in the number of melanoma screenings at this clinic. The
following discussion outlines the results from each of the project objectives.
Conducting the Lunch
and Learn Session
The first objective of this scholarly project was to develop a lunch and learn
session, which was done during the first week of August after the approval from the
institutional review boards of the clinic and the University of Northern Colorado.
Two separate sessions were held for medical assistants and providers regarding
melanoma and the implementation of the DNP scholarly project. The pre- and postsurvey questionnaires were given to the medical assistants and the providers, and
questions regarding melanoma and DNP scholarly project were answered. The staff at
the clinic was generous of their time by participating and providing their feedback.
The staff participated in the lunch and learn session with an open and growth mindset
to learn more about melanoma and improve patient care.
The lunch and learn session was an effective method to have all the team
members of the clinic together. The project lead was able to obtain the baseline
assessment of the understanding and knowledge of the staff on melanoma and
melanoma screening at the clinic via pre-survey questionnaires. Also, the staff was
able to learn about the doctoral project including melanoma, workflow algorithm, and
SAMScore prior to the implementation of the project. The feedback from the staff
during the lunch and learn session was appreciated and considered by the project lead,
such as having a separate sheet of paper with the inclusion and exclusion criteria
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behind the nurse’s desk for easy access. The lunch and learn session helped in
clarifying questions that medical assistants and providers had regarding the project
implementation and assisted in the smooth implementation of the project. It is highly
recommended that a similar session to the lunch and learn session be performed prior
to a quality improvement project in a healthcare setting.
There was an increase in the number of correct answers for the inclusion
criteria, exclusion criteria, and role of the medical assistants with the completed
SAMScores while comparing the pre-survey and post-survey questionnaires for the
medical assistants. Previously, studies have focused on educating providers on
melanoma and its screening, but not other staff within a clinic setting. One study by
Robinson et al. (2018) looked at the knowledge and skills of 89 primary care providers
by analyzing a pretest and posttest assessment before and after completing the mastery
learning course. The study showed that the primary care providers in the intervention
group were able to correctly identify melanomas in the posttest, had fewer false
positives, and referred fewer benign lesions than the control group (Robinson et al.,
2018). Furthermore, the mastery learning course improved the detection of early
melanoma and patient care, decreasing unnecessary procedures, financial burdens, and
time burdens (Robinson et al., 2018). Similarly in this project, the providers improved
their understanding of risk factors for melanoma and criteria for a positive SAMScore
after the education session. Additionally, in this project, the providers demonstrated
an increase in the intention to continue to utilize the algorithm, SAMScore, and
melanoma early detection provider toolkit to increase melanoma screening at the
clinic. No other studies were found that evaluated the intention of the providers on
melanoma screening interventions.
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Key facilitators. One of the biggest facilitators for the success of the lunch
and learn session was a positive attitude and open-mindedness of the medical
assistants and providers to learn about melanoma and improve patient care. In
addition, the medical assistants and providers found the PowerPoint on melanoma,
workflow algorithm, and SAMScore to be very helpful. Also, any questions on the
project were answered immediately during the session.
Key barriers. One of the key barriers was difficulty in finding time to have
medical assistants and providers meet for the lunch and learn session at the same time.
It was a challenge to have medical assistants and providers to meet the project lead at
the same time. Thus two separate sessions were held for medical assistants and
providers. Both providers had their computers with them and were charting during the
lunch and learn session which could have affected their attention to the lunch and
learn session.
Implement a Pilot of Evidencebased Melanoma Workflow
Algorithm
After the successful lunch and learn session, the algorithm was implemented
on the same day. Questions from the medical assistants and providers were answered.
The inclusion and exclusion criteria of the project were written on a paper and taped to
the nurse’s station with a secure folder for consents and completed SAMScores per the
request of the staff of the clinic. The staff was informed that the project lead would be
at the clinic twice a week during the implementation period or as needed. The cell
phone number of the project lead was shared with the medical director of the clinic to
call the project lead with any questions regarding the project.
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Throughout the implementation of the project, the medical director and the
project lead were in contact via telephone updating the project lead on the
implementation process and the number of screened patients. The medical director
and the staff of the clinic continued to give feedback on the project. There were a total
of 10 patients who met the inclusion criteria for the project and only nine completed
the SAMScore. Out of nine completed SAMScores, one was completed outside the
implementation month; thus it was not included in the result of the project. Also, one
patient did not consent to participate in the study but completed the SAMScore. Thus
only eight completed SAMScores and eight completed consent forms were included in
the project.
Only eight completed SAMScores and eight completed consent forms were
included in the DNP scholarly project. Out of eight completed SAMScores, there
were three patients who were positive for a SAMScore. The providers also stated that
the project increased their awareness of skin lesions and melanomas. As a result, one
provider performed two biopsies in the clinic during the intervention month.
However, the biopsies came back negative for melanomas. Also, no biopsies were
performed on patients who were positive for a SAMScore since they did not have any
suspicious lesions during the full-body skin exam. A similar study was done using the
SAMScore to identify the patients at high-risk or not for melanoma in France. For
those patients who were identified as high-risk for melanoma, they received an
invitation via mail to consult with their primary care providers for annual skin
examination (Rat et al., 2015). Based on the provider’s discretion, primary care
providers either performed total skin examination or referred patients to
dermatologists as needed (Rat et al., 2015). Out of 3,745 patients who received a mail
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invitation, 61% consulted with their primary care providers and 16% consulted with a
dermatologist (Rat et al., 2015). There were a total of 83 patients who had suspicious
lesions and had excisions (Rat et al., 2015). Furthermore, there were six melanomas,
five squamous cell carcinomas, and 15 basal cell carcinomas diagnosed (Rat et al.,
2015).
Key facilitators. One of the key facilitators of the implementation of the
project was the readiness of the staff and the design of the project. The five medical
assistants, two providers, and patients who participated in this project were eager to
learn about melanoma, identify patients at high risk for melanoma in the community,
improve the melanoma screening using the evidence-based melanoma workflow
algorithm, and educate patients on the prevention of melanoma and non-melanoma
skin cancers. The staff at the clinic was ready to start the project and said that the
design of the project was well planned and easy to follow. The patients who met the
inclusion criteria of the project were excited about the project and appreciated the staff
for implementing such an important topic in a primary care setting. The
implementation of the project would not have been successful if the staff and patients
were not devoted to the project.
Key barriers. One of the biggest barriers to the implementation of the DNP
scholarly project was the lack of validation of the SAMScore in languages except for
English and French. Due to this limitation, the inclusion and exclusion criteria of the
project were narrow and not able to include a larger number of the patient population,
even though there were patients who might have been at higher risk for melanoma or
non-melanoma skin conditions. Another barrier was the size of the clinic with the
limited number of staff. One of the providers reported that one of the barriers to the
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project was that it was a DNP project, and medical assistants were not as familiar with
the rigor and details of a DNP project as compared to any clinic-based quality
improvement project. The provider added if it was just a quality improvement project
rather than being a DNP project without strict rules on inclusion and exclusion criteria,
it would have resulted into a higher number of melanoma screenings. Attempts were
made throughout the implementation month to educate the medical assistants
regarding the inclusion and exclusion criteria of the project and the overall DNP
project.
Appraise the Number of Patients
Identified as High Risk
for Melanoma
The chart review was performed by the project lead for the control and the
intervention month. There were only two melanoma screenings that were performed
during the control month of April 2019 between the two providers. The melanoma
screening increased to eight screenings during the intervention period after the
implementation of the melanoma algorithm and the SAMScore at the clinic. The
patients were identified as high risk for melanoma or not based on their responses in
the SAMScore and if they met any one of the criteria of the SAMScore. Two other
studies (Quereux et al., 2012; Rat et al., 2015) utilized the SAMScore to identify
patients who were at high risk for melanoma. The studies by Rat et al. (2015) and
Quereux et al. (2012) identified 3,897 patients and 2,404 patients as high risk for
melanoma, respectively, using the SAMScore. Once they were identified as high risk
for melanoma, they were then advised to consult with either their primary care
providers or dermatologists (Quereux et al., 2012; Rat et al., 2015).
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Key facilitators. During the implementation month, the two providers and the
five medical assistants identified the patients who met the inclusion criteria of the
study every morning by looking at the schedule for the day. This helped to ensure that
all the patients meeting the inclusion criteria received the consent forms and
SAMScore prior to being seen by the providers. Having the SAMScore and consent
forms in two separate colors helped to make sure that each patient received both
during their appointment time and that those documents did not get lost during the
process. Again, the SAMScore was very easy to read and follow and assisted
providers to decide if the patient was at high risk for melanoma or not.
Key barriers. One of the barriers was the strict inclusion and criteria of the
study for the patients to participate. According to the staff of the clinic, there were
patients who were interested in the study, but they did not meet the inclusion and
exclusion criteria for the study due to language, age, and type of visit. Another barrier
to this DNP scholarly project was the validation of the SAMScore. Since the
SAMScore was only validated in the English and French languages, the model could
not be used for people who were not able to speak, read, or write in either the English
or French language. Spanish was the second most common language at the clinic
where the project was implemented, making it hard to screen the Hispanic population
who were not able to speak, read, and write English.
Another important barrier was the time that providers had for one patient. The
providers only had 20 minutes for one patient at either acute care visits or annual
wellness visits. Even if the patient had an annual wellness visit as their chief
complaint, most of the patients had several comorbid conditions or the visit ended up
being an acute care visit, and the providers felt like they did not have time to talk
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about melanoma screening or perform a full-body skin exam even if the patients were
at high risk.
Appraise the Number of Patients
Positive and Negative for
Self-Assessment of Melanoma Risk Score and
Interventions for the
Ones with Positive
Self-Assessment of
Melanoma Risk
Score
The chart review of the intervention month showed that there was a total of
three positive SAMScores among the consented patients. All three patients had
keywords, international classification of diseases (ICD) 10 code and interventions
charted in their electronic health record. For the patients who had positive
SAMScores and did not have any suspicious lesions or skin issues that led providers to
perform biopsy or refer them to the dermatologists, the providers noted in the plan
section of the electronic health record that those patients were positive for the
SAMScore or at high risk for melanoma needing annual skin exam. As a result, those
patients would be followed up and would be screened for melanoma every year during
their annual wellness visits. If any suspicious lesion was found by the providers
during the full-body skin examination, appropriate intervention such as biopsy or
referral would be immediately done by the providers. There were five patients with a
negative SAMScore, which means that they were not at high risk for melanoma at the
time of the visit. Having a negative SAMScore does not mean that those patients
would or would not have melanoma in the future. But it is important to continue to
screen those patients to assess their most current risk for developing melanoma using
the SAMSocre. All the patients who were positive and negative for the SAMScore
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received the primary prevention handout from the American Association of
Dermatology. The combination of the SAMScore and primary care providers’
examination and counseling is an efficient way to promote patient behaviors that may
reduce melanoma risk (Rat et al., 2014). Furthermore, identification of the patients
who are at high risk for melanoma allows the primary care providers to focus their
attention, energy, and time on educating those patients (Rat et al., 2014).
Key facilitators. The design of the project made it easier to collect the data for
the patients who were positive and negative for SAMScore and related interventions.
The providers were educated during the lunch and learn session to chart in the
electronic medical record if the patients who filled out the SAMScore were positive or
negative for the SAMScore and related interventions such as biopsy, referral, or
annual skin exam.
Key barriers. As mentioned above, one of the key barriers to the appraisal of
the number of patients positive and negative for a SAMScore was the lack of
validation of the SAMScore in the Spanish language. If the SAMScore would be
validated in the Spanish language, it would broaden the inclusion criteria of the
project, making it possible to include the Hispanic population. This would have
resulted in a greater number of patients screened for melanoma. As a result, it would
increase the number of patients who were positive and negative for a SAMScore.
Another barrier included the short timeframe. The implementation period of the DNP
scholarly project was only one month, which was insufficient to assess the
effectiveness of the project. It would be interesting to see the result if the project
would be implemented for a longer period of time such as six months to one year. If
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the project was implemented for a longer period of time, it would have been possible
to catch melanoma during that timeframe.
Report an Increase in the Intention
Among Providers and
Medical Assistants
With the pre-, post-, and post-post-survey questionnaires, providers reported
that they intend to increase the melanoma screening using the melanoma workflow
algorithm and SAMScore. Both providers stated that they intended to use the
melanoma early detection provider toolkit as a resource. One of the providers asked
the project lead if the clinic could continue to use the printed SAMScore even after the
intervention month to improve melanoma screening rate of the clinic. All five medical
assistants reported that the design of the DNP Scholarly project was well planned and
the SAMScore was simple and easy for the patients to use with minimal to no input
from the staff members in completing the SAMScore. There are no studies with
SAMScore that evaluated the intention of the staff to continue to use the SAMScore.
This is the first project that asked specific questions on the intention of the providers
to continue to use SAMScore and melanoma early detection provider toolkit.
Key facilitators. The design of the project made it easier to collect the data on
the intention of the providers to continue to use the SAMScore, workflow algorithm,
and melanoma early detection provider toolkit since there were yes/no questions in the
pre-, post-, and post-post-survey.
Key barriers. Even though the providers stated that they intended to use the
melanoma early detection provider toolkit in their pre-, post-, and post-post-survey,
none of the providers had signed up or completed the toolkit by the end of the
implementation month. The key barrier to the lack of participation in the toolkit was

98

the time and length of the toolkit to complete all modules. However, the providers
reported that they would keep the toolkit in mind and would keep it as a resource for
future reference.
Limitations
The DNP scholarly project was developed and implemented with an intention
to increase melanoma screening in a primary care setting by the primary care
providers and improve the staff’s knowledge and confidence level at screening
patients for melanoma. However, one of the limitations was the duration and timing
of the quality improvement project. There were a lower number of patients who met
the inclusion and exclusion criteria of the project than expected prior to the
implementation of the project. The duration of one month for the implementation and
chart review was not adequate; as a result, the completed SAMScore was not scanned
into the electronic health records for the project lead to compare with the original
SAMScore. The whole team was extremely supportive and appreciative of
implementing the DNP scholarly project at the clinic.
Recommendations
Further study is needed to validate the SAMScore in languages other than
English and French. Also, the same project could be done for a longer period of time
to evaluate the effectiveness of the SAMScore in the same clinic and compare it to the
results of the current project. Further study can be done if there is another risk
prediction model that is comparable or simple, easy, and applicable in a primary care
setting to identify patients at high risk for melanoma or skin cancers. In addition, the
project could easily be replicated in a clinic with a higher number of providers and
patients.
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The clinic celebrates the month of May as skin cancer awareness month, where
the clinic conducts free skin cancer screening. Once the SAMScore is translated and
validated in other languages, especially Spanish, it can be used to identify patients at
risk for melanoma and can be distributed to the majority of the patients seen at the
clinic over the month of May. Furthermore, the primary prevention handout from the
American Academy of Dermatology can also be used to educate patients on
melanoma.
In the future, it would be important to collaborate with the information
technology department of the clinic to integrate the SAMScore into the electronic
medical records of the patients. The SAMScore can be laminated and used by the
patients during their appointment, which then can be translated into the electronic
medical record by the medical assistants. This saves the amount of paper used for the
SAMScore and saves time for the medical records department to scan the SAMScore
into the charts; paper can be easily misplaced or not labeled with the correct patient’s
identifiers. Another recommendation would be to utilize an electronic system such as
an Ipad with a built-in SAMScore that can still be filled out by the patient while
waiting for providers. This also makes it easy for the providers to access all the
medical records of the patients rather than in the scanned document of the electronic
medical records.
The Donabedian model was used as a foundation for the scholarly DNP
project. The three frameworks of the Donabedian model, structure, process, and
outcome, helped the project lead to assess the current structure of the clinic and
melanoma screening process at the clinic, identify the barriers to the melanoma
screening, develop a melanoma screening workflow algorithm for the clinic, and
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evaluate the outcome of the implementation of the algorithm at the clinic. It is
recommended that this model be used as a guide for future studies or projects related
to improving melanoma screening at any facility.
There was a minimal budget planned for this scholarly DNP project. The cost
included the time of the clinic staff for the educational training sessions, time of the
DNP student, and lunch provided at the lunch and learn session. There were gifts, or
monetary compensation, to the clinic staff. The providers did not review or login into
the melanoma early provider toolkit from the Oregon Health and Science University
(OHSU), Department of Dermatology, since the toolkit was time-consuming. Moving
forward, offering an incentive to the providers to complete the education on melanoma
might have resulted in an increased number of participations in completing the toolkit
since the toolkit had great information on melanoma.
Attainment of Personal Goals
This DNP scholarly project offered a great learning experience to the project
lead and the staff at the clinic regarding melanoma, the importance of screening for
melanoma, detecting melanoma early, and the important role of primary care providers
at identifying high-risk patients for melanoma. The project lead grew from being a
novice student on melanoma to an expert on melanoma and its screening. The
limitations, barriers, and facilitators of the DNP scholarly project provided insight into
having a standardized and evidence model to screen high-risk patients for melanoma.
The whole process of choosing a DNP project topic to perform a literature review to
writing all five chapters was challenging and exhausting. Despite those limitations,
barriers, and facilitators, the DNP scholarly project taught the project lead about
resilience and to have a growth mindset.
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Essentials of Doctoral Education for
Advanced Nursing Practice
The American Association of Colleges of Nursing proposed that a DNP final
project must meet the outcomes of the American Association of Colleges of Nursing
Essentials of Doctoral Education in Advanced Nursing Practice using the five criteria
(Waldrop, Caruso, Fuchs, & Hypes, 2014). The five criteria are enhances,
culmination, partnerships, implements, and evaluation. The essentials were integrated
into this scholarly DNP project, and the five criteria were used to demonstrate how the
project aligned with the American Association of Colleges of Nursing Essentials of
Doctoral Education.
The first criterion is enhancing health outcomes, practice outcomes, or
healthcare policy (Waldrop et al., 2014). This scholarly DNP project identified the
need for melanoma screening in primary care to identify the patients at risk for
melanoma and reduce the morbidity and mortality rate associated with it so that
appropriate treatment could be started as soon as possible. A literature review on
melanoma screening was performed and the barriers to melanoma screening at the
clinic were identified. This led to the identification of the best risk prediction model
for melanoma and developing a melanoma screening workflow algorithm for the clinic
to enhance or improve patient outcomes.
The second criterion is reflecting a culmination of practice inquiry (Waldrop et
al., 2014). The project lead also identified a gap between the literature and knowledge
that a change in melanoma screening in primary care was necessary, and it was the
right time to bring that change. An exhaustive literature review on melanoma
screening was completed. The barriers of the clinic and the providers on melanoma
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screening were identified and, a melanoma screening workflow algorithm was
developed that was practical and easy to implement. The electronic medical record
was used to perform the chart reviews of the patients for the control and intervention
month.
The third criterion is requiring engagement in partnerships (Waldrop et al.,
2014). Partnership and collaboration with the manager, providers, medical assistants,
and patients of the clinic made the DNP scholarly project a success. There was open
communication between all the team members regarding the project and any questions
were timely answered. The project was also approved by the institutional review
boards of the clinic and the University of Northern Colorado. The constructive
feedbacks were provided by the team from the start to the completion of the scholarly
DNP project.
The fourth criterion is implementing or applying or translating evidence into
practice (Waldrop et al., 2014). The SAMScore was found to be the best, effective,
efficient, and validated risk prediction model to identify high-risk patients for
melanoma. The model was used to screen patients for melanoma at the clinic. Based
on the literature and constructive feedback from the staff of the clinic, inclusion and
exclusion criteria were determined. As a result, the evidence-based melanoma
screening workflow algorithm was developed and successfully translated into practice.
The last and fifth criterion is the evaluation of healthcare, practice, or policy
outcomes (Waldrop et al., 2014). The evaluation of the project was done after
exhaustive literature review and implementation of the scholarly DNP project. It was
determined that the SAMScore was simple, easy to implement, and was an effective
model in assessing patients’ risk for melanoma. The project can be easily reproduced
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and is sustainable as the clinic continues to use the SAMScore and the American
Academy of Dermatology handout on primary prevention of melanoma even after the
implementation month.
Conclusion
The incidence and prevalence rate of melanoma is increasing worldwide, and it
is a significant public health concern (Alendar, Drljevic, Drljevic, & Alendar, 2009).
Melanoma is a challenging disease for a provider to detect, and it is not possible to
perform full-body skin examination on every patient seen in a primary care clinic.
Also, not every patient sees a dermatologist regularly to have their skin checked. In
addition, there is a lack of standardized guidelines on the melanoma screening that can
be utilized in a primary care setting.
Early detection of melanoma is important to decrease the mortality as the
disease is highly curable at an early stage (Fleming et al., 2018). Also, primary care
providers can improve early the detection of melanoma directly by performing
biopsies of suspicious lesions and referring patients to a dermatologist (Fleming et al.,
2018). To improve early detection of melanoma, it is important that patients are
screened for melanoma and are identified if they are at high risk for melanoma or not.
As a result, the DNP scholarly project utilized the SAMScore and melanoma
screening workflow algorithm at a small rural clinic in Northern Colorado with a goal
to improve melanoma screening and identify patients at high risk for melanoma. The
implementation of the project showed that there was a 300% increase in the number of
patients who were screened for melanoma during the intervention months of
August/September 2019 compared to the control month of April 2019. Furthermore,
the SAMScore and melanoma screening workflow algorithm was found to be effective
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at identifying patients at high for melanoma. Both interventions were simple and easy
to use with minimal to no input from the staff. The project also improved and
increased awareness of the staff and patients on melanoma. Further studies are needed
to validate the SAMScore in different languages, continue the same project for a
longer duration, and replicate the same project in a larger clinic.
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CONSENT FORM FOR HUMAN PARTICIPATIONS IN PROJECT
Project Title: Screening for melanoma for at-risk population: A Practice Guide
Researcher: Sapana Shakya, RN-BSN, Doctor of Nursing Practice Student
Email: shak5662@bears.unco.edu
Committee Chair: Melissa Henry, PhD, RN, FNP-C
University of Northern Colorado, School of Nursing, Gunter Hall 3340
Greeley, CO 80639
Email: Melissa.Henry@unco.edu
General Purpose of the study: The purpose of this project is to implement an evidencebased melanoma screening algorithm utilizing SAMScore to identify patients at high
risk for melanoma in a primary care setting by primary care providers in an effort to
facilitate early detection and initiate treatments to minimize the complications related
to melanoma.
Procedure: You will be given a bright yellow sheet of paper with total of seven
questions by the medical assistants. You will be asked to complete the questionnaire
independently while you are waiting to see the providers. You will also be asked not
to put any patient identifiers on the sheet such as name, age, sex, or ethnicity. You
will then hand your completed paper to the provider to review your risk for melanoma.
Only the providers, the medical assistants, and the student project lead will have a
record of the data collected. The data collected will be confidential. The original
document will be copied, and the copy will be scanned to your medical record. The
original document will be stored in a confidential folder behind the nurses’ station for
the student to collect. The collected data will be destroyed once the project is
completed. The project lead will review your chart for age, gender, risk factors for
melanoma or skin cancer, documentation of melanoma or skin cancer screening, and
intervention or education regarding melanoma or skin cancer.
Disclosure risk: Potential risks to participants in this project are minimal. Risk
includes potential patient embarrassment to undress or lift clothing for providers to
assess the skin for melanoma or skin cancer. There is a minimal risk of identifying
you as a participant since the collected document will not have any patient identifiers.
Direct benefits: Direct benefits as a participant include identification as high or low
risk for melanoma or skin cancer, early detection of skin lesions if any, and
appropriate interventions. Early identification of a melanoma is a lifesaver. Another
benefit in participating in the project is increased awareness of the risk factors for
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melanoma and learning primary and secondary prevention measures for melanoma or
other skin cancers.
Participation: Participation in this project is voluntary. If you wish to not participate
in the project, you are free to do so at any time. You may simply verbalize your wish
to withdraw from the project by notifying the medical assistant or the providers at the
clinic. Your decision to participate or not participate will not affect you or your
treatment at the clinic.
Confidentiality: Your confidentiality will be protected. There will be no patient
identifiers attached to your completed document. The completed document will be
kept safe in a confidential folder at the back of the nurses’ desk. Only the medical
assistants, the providers and the project lead will have access to the data collected.
Participation is voluntary. You may decide not to participate in this study and if you
begin participation you may still decide to stop and withdraw at any time. Your
decision will be respected and will not result in loss of benefits to which you are
otherwise entitled. Having read the above and having had an opportunity to ask any
questions, please sign below if you would like to participate in this research. A copy
of this form will be given to you to retain for future reference. If you have any
concerns about your selection or treatment as a research participant, please contact
Nicole Morse, Office of Research, Kepner Hall, University of Northern Colorado
Greeley, CO 80639; 970-351-1910.

_________________________
Participant Printed Name:
__________________________
Date:

__________________________
Signature:
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NO SIGNATURE CONSENT FORM FOR HUMAN PARTICIPANTS IN
RESEARCH
UNIVERSITY OF NORTHERN COLORADO
Project Title: Screening for Melanoma for At-risk Population: A practice guide
Researcher: Sapana Shakya, RN, BSN, FNP-DNP student
-Phone Number: xxx-xxx-xxxx
e-mail: shak5662@bears.unco.edu
I am conducting a scholarly project to improve the number of melanoma screening for
at risk population in a primary care clinic by the primary care providers. As a
participant in this project, you will be asked to complete pre-, post- and post-post
survey questionnaires. The pre-survey questionnaires will be given to you to complete
prior to “the lunch and learn session”. The post-survey questionnaires will be given to
you to complete after “the lunch and learn session”. The post-post survey
questionnaires will be given to the providers only at the end of the implementation of
the project. All three questionnaires consist of multiple-choice questions, fill in the
blanks and open- ended questions. The questionnaires will assess your understanding
of self-assessment of melanoma risk score (SAMScore) and the project algorithm.
Each questionnaire will take approximately 3-5 minutes to complete.
For the survey questionnaires, you will not provide your name, but will be asked to
provide survey identification which includes numerical format of the birthday month
and date. Therefore, your responses will be confidential. Only the project lead and
the medical director of the clinic will have access to the completed survey
questionnaire and written feedback will be used to make changes to the project as
needed. The result of the survey questionnaires will be presented to the project chair,
committee members and other students or members who attend the project lead’s final
defense at the University of Northern Colorado. All the original survey questionnaires
will be stored in a confidential folder inside the office of the medical director of the
clinic and will be destroyed at the end of the project implementation.
Risks to you are minimal. You should not feel anxious or frustrated taking the survey
questionnaires since the survey questionnaires are straight forward and easy to
understand. The benefits to you include increased awareness and knowledge on
melanoma, melanoma screening, and interventions to prevent melanoma.
Participation is voluntary. You may decide not to participate in this study and if you
begin participation you may still decide to stop and withdraw at any time. Your
decision will be respected and will not result in loss of benefits to which you are
otherwise entitled. Please take your time to read and thoroughly review this document
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and decide whether you would like to participate in this research study. If you decide
to participate, your completion of the research procedures indicates your consent.
Please keep or print this form for your records. If you have any concerns about your
selection or treatment as a research participant, please contact Nicole Morse, Office
of Research, Kepner Hall, University of Northern Colorado Greeley, CO 80639; 970351-1910.
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INDIVIDUAL INVESTIGATOR AGREEMENT FORM
FOR MEDICAL ASSISTANTS

134

Individual Investigator Agreement
Name of Institution with the Federalwide Assurance (FWA): University of
Northern Colorado
Applicable FWA #: FWA00000784
Individual Investigator’s Name:
____________________________________________________
Specify Research Covered by this Agreement: Screening for Melanoma for At-risk
Population: A practice guide
UNC PIs: Sapana Shakya and Advisor, Dr. Melissa Henry

(1) The above-named Individual Investigator has reviewed: 1) The Belmont Report:
Ethical Principles and Guidelines for the Protection of Human Subjects of
Research (or other internationally recognized equivalent; see section B.1. of the
Terms of the Federalwide Assurance (FWA) for International (Non-U.S.)
Institutions); 2) the U.S. Department of Health and Human Services (HHS)
regulations for the protection of human subjects at 45 CFR part 46 (or other
procedural standards; see section B.3. of the Terms of the FWA for International
(Non-U.S.) Institutions); 3) the FWA and applicable Terms of the FWA for the
institution referenced above; and 4) the relevant institutional policies and
procedures for the protection of human subjects.
(2) The Investigator understands and hereby accepts the responsibility to comply with
the standards and requirements stipulated in the above documents and to protect
the rights and welfare of human subjects involved in research conducted under this
Agreement.
(3) The Investigator will comply with all other applicable federal, international, state,
and local laws, regulations, and policies that may provide additional protection for
human subjects participating in research conducted under this agreement.
(4) The Investigator will abide by all determinations of the Institutional Review Board
(IRB) designated under the above FWA and will accept the final authority and
decisions of the IRB, including but not limited to directives to terminate
participation in designated research activities.
(5) The Investigator will complete any educational training required by the Institution
and/or the IRB prior to initiating research covered under this Agreement.
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(6) The Investigator will report promptly to the IRB any proposed changes in the
research conducted under this Agreement. The investigator will not initiate
changes in the research without prior IRB review and approval, except where
necessary to eliminate apparent immediate hazards to subjects.
(7) The Investigator will report immediately to the IRB any unanticipated problems
involving risks to subjects or others in research covered under this Agreement.
(8) The Investigator, when responsible for enrolling subjects, will obtain, document,
and maintain records of informed consent for each such subject or each subject’s
legally authorized representative as required under HHS regulations at 45 CFR
part 46 (or any other international or national procedural standards selected on the
FWA for the institution referenced above) and stipulated by the IRB/IEC.
(9) The Investigator acknowledges and agrees to cooperate in the IRB’s responsibility
for initial and continuing review, record keeping, reporting, and certification for
the research referenced above. The Investigator will provide all information
requested by the IRB in a timely fashion.
(10) The Investigator will not enroll subjects in research under this Agreement prior to
its review and approval by the IRB.
(11) Emergency medical care may be delivered without IRB review and approval to the
extent permitted under applicable federal regulations and state law.
(12) This Agreement does not preclude the Investigator from taking part in research not
covered by this Agreement.
(13) The Investigator acknowledges that he/she is primarily responsible for
safeguarding the rights and welfare of each research subject, and that the subject’s
rights and welfare must take precedence over the goals and requirements of the
research.
Investigator Signature: ____________________________ Date _______________
Name: _________________________________________ Degree(s): _____________
(Last)
(First)
(Middle Initial)
Address: _____________________________________ phone #: ________________
________________________________________________
(City)
(State/Province)
(Zip/Country)
FWA Institutional Official (or Designee): __________________ Date ___________
Dr. Mark Anderson, Provost
Address:

501 20th Street, Greeley, Colorado 80639; 970-351-2305
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APPENDIX I
SELF-ASSESSMENT OF MELANOMA RISK SCORE
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Please DONOT put any patient identifier (NO NAME/AGE/GENDER) on this paper
Answer each question by checking the appropriate square.
1. What type of skin do you have?
o Skin-type I: Very fair skin, blond or red hair, light eyes (blue or green),
never tan and always sunburn after sun exposure.
o Skin-type II: Fair skin, blond or light brown hair, light eyes (blue or
green), usually sunburn.
o Skin-type III: Dark skin, brown hair, light to medium eye color.
o Skin-type IV: Olive skin, dark brown hair, brown eyes.
o Skin-type V: Brown skin, black hair, black eyes.
o Skin-type VI: Black skin, black hair, black eyes.
2. Do you have freckles?
o Yes
o No
3. How many moles do you approximately have on both arms?
o More than 20
o Fewer than 20
4. Have you had one or more episodes of severe blistering sunburn during
childhood or teenage years?
o Yes
o No
5. Did you live more than 1 year in a country where sunshine is high (Africa,
French West Indies, South of United States, Australia)?
o Yes
o No
6. Have you been diagnosed with melanoma in the past (It is a skin cancer,
arising in melanocytes, skin cancer that make skin pigment?
o Yes
o No
7. Has any of your first-degree relatives (parents, children, brother or sister) ever
had melanoma?
o Yes
o No
According to the SAMScore, a patient is considered at risk for melanoma if at least
one of these 3 criteria is verified:
First criterion: Presence of at least 3 risk factors among the 7 following risk
factors: phototype I or II, freckling tendency, number of melanocytic nevi >20 on both
arms, severe sunburn during childhood or teenage years, life in a country at low
latitude, a history of previous melanoma, a history of melanoma in a first-degree
relative.
Second criterion: A subject under 60 years of age and a number of
melanocytic nevi >20 on both arms
Third criterion: A subject of 60 years old or over and a freckling tendency
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APPENDIX J
RETROSPECTIVE CHART REVIEW
DATA COLLECTION
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RETROSPECTIVE CHART REVIEW DATA COLLECTION
Number of Annual visits

Number of Establish visits

Melanoma Screening

Total Number of Patients

Yes
No
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APPENDIX K
INSTITUTIONAL REVIEW BOARD APPROVAL
(AMENDMENT)
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APPENDIX L
INTERVENTION CHART REVIEW
DATA COLLECTION
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INTERVENTION CHART REVIEW DATA COLLECTION
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APPENDIX M
PRE-SURVEY QUESTIONNAIRE (PROVIDERS)
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PRE-SURVEY QUESTIONNAIRE (Providers)
Providers: Please fill out the following questionnaire to assist the project lead in
identifying current practice and provide barriers/feedbacks/suggestions for melanoma
screening in primary care.
1. Do you currently screen patients for melanoma or skin cancer during their
annual wellness visits?
o Yes
o No
2. What percentage approximates the number of patients you currently screen?
o 100%
o 75%
o 50%
o 25%
o 0%
3. Have you heard or learned about SAMScore for melanoma screening?
o Yes
o No
4. If answered Yes to question 2, where did you hear or learn about SAMScore?
If answered No to question 2, Go to question 7.

5. How many risk factors on the SAMScore are needed for the patient to be
considered at risk for melanoma?
o 1
o 2
o 3
o 4
6. Please check the appropriate boxes for the positive SAMScore
o At least 3 of the 7 risk factors
o Older than 60 with more than 20 nevi on both arms and freckles
o Younger than 60 with more than 20 nevi on both arms
o Older than 60 with freckling tendency
7. The ICD 10 code and key words in plan section of the SOAP note will be used
by the project lead to evaluate the objectives.
o True
o False
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8. Have you heard or learned about melanoma early detection provider toolkit
through OSHU or any toolkit for melanoma screening?
o Yes
o No
9. Would you intend to use melanoma early detection provider toolkit as a
resource for melanoma screening?
o Yes
o No
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:
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APPENDIX N
POST-SURVEY QUESTIONNAIRE (PROVIDERS)
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POST-SURVEY QUESTIONNAIRE (Providers)
Providers: Please fill out the following questionnaire to assist the project lead in
identifying your intention, understanding of the algorithm and SAMScore and provide
barriers/feedbacks/suggestions for melanoma screening in primary care.
1. After participating in the melanoma screening “lunch and learn session”, do
you intend to change your current screening practice for melanoma or skin
cancer by incorporating SAMScore or evidence-based melanoma algorithm to
a greater number of patients during
annual wellness visits?
a. Yes
b. No
2. How many risk factors on the SAMScore are needed for the patient to be
considered at risk for melanoma?
a. 1
b. 2
c. 3
d. 4
3. Please check the appropriate boxes for the positive SAMScore
a. At least 3 of the 7 risk factors
b. Older than 60 with more than 20 nevi on both arms and freckles
c. Younger than 60 with more than 20 nevi on both arms
d. Older than 60 with freckling tendency
4. The ICD 10 code and key words in plan section of the SOAP note will be used
by the project lead to evaluate the objectives.
o True
o False
5. Do you intend to use melanoma early detection provider toolkit as a resource
for melanoma screening?
a. Yes
b. No
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:
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APPENDIX O
POST-POST SURVEY QUESTIONNAIRE
(PROVIDERS)
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POST-POST SURVEY QUESTIONNAIRE (Providers)
Providers: Please fill out the following questionnaire to assist the project lead in
identifying providers intention to utilize the algorithm and resources.
1. Do you intend to continue to screen patients for melanoma or skin cancer
during their annual wellness visits?
c. Yes
d. No

2. Do you intend to use the melanoma screening algorithm developed for this
practice or different melanoma early detection provider toolkit as a resource
for melanoma screening in the future?
a. Yes
b. No
Barriers/Feedbacks/Suggestions to melanoma screening in primary care you
encountered during the melanoma screening pilot project:
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APPENDIX P
PRE-SURVEY QUESTIONNAIRE
(MEDICAL ASSISTANTS)
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PRE-SURVEY QUESTIONNAIRE (Medical assistants)
Medical assistants: Please fill out the following questionnaire to assist the project lead
in identifying your understanding of project lead’s melanoma screening algorithm and
SAMScore and provide barriers/feedbacks/suggestions to improve melanoma
screening in primary care.
1. Have you heard or learned about SAMScore for melanoma screening?
o Yes
o No
2. If answered Yes to question 1, where did you hear or learn about SAMScore?

3. The inclusion criteria for the patients to have the SAMScore includes.
o Patients younger than 35 and older than 75 for acute visits
o Patients aged 35-75 presenting for their annual physical
o Able to read, write and speak English
o English and Spanish speakers
4. The exclusion criteria for the patients to not have the SAMScore includes.
o Patients younger than 35 and older than 75 for acute visits
o Patients aged 35-75 presenting for their annual physical
o Able to read, write and speak English
o English and Spanish speakers
o Well women visits
5. Medical assistants will make a copy of the Original SAMScore filled out by
patients, copied SAMScore will be scanned into the electronic health record
and the original will be stored securely in a folder for the project lead to
collect.
o True
o False
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:
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APPENDIX Q
POST-SURVEY QUESTIONNAIRE
(MEDICAL ASSISTANTS)
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POST-SURVEY QUESTIONNAIRE (Medical assistants)
Medical assistants: Please fill out the following questionnaire to assist the project lead
in identifying your understanding of project lead’s melanoma screening algorithm and
SAMScore and provide barriers/feedbacks/suggestions to improve melanoma
screening in primary care.
1. The inclusion criteria for the patients to have the SAMScore includes.
o Patients younger than 35 and older than 75 for acute visits
o Patients aged 35-75 presenting for their annual physical
o Able to read, write and speak English
o English and Spanish speakers
2. The exclusion criteria for the patients to not have the SAMScore includes.
o Patients younger than 35 and older than 75 for acute visits
o Patients aged 35-75 presenting for their annual physical
o Able to read, write and speak English
o English and Spanish speakers
o Well women visits
3. Medical assistants will make a copy of the Original SAMScore filled out by
patients, copied SAMScore will be scanned into the electronic health record
and the original will be stored securely in a folder for the project lead to
collect.
o True
o False
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:
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APPENDIX R
HANDOUT FROM AMERICAN ASSOCIATION
OF DERMATOLOGY
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APPENDIX S
PERMISSION E-MAIL FROM AMERICAN
ASSOCIATION OF DERMATOLOGY
TO USE HANDOUT
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APPENDIX T
MELANOMA SCREENING WORKFLOW
ALGORITHM FOR PROVIDERS
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Melanoma screening workflow algorithm for at-risk population in primary care
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APPENDIX U
MELANOMA SCREENING WORKFLOW
ALGORITHM FOR MEDICAL
ASSISTANTS
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Melanoma screening workflow algorithm for Medical Assistant at the clinic

